image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
a106c28de0575ae3c459fbb751c3fb05c64a6e87e689129761a3a3cc5c8d0677.png | complex | <table><tr><td>Outcome</td><td>RCN (monetized)</td><td>ASBL (monetized)</td><td>SER (monetized)</td><td>ASBL + SER (monetized)</td></tr><tr><td>Cycling mode share by 2051 (%)</td><td>5</td><td>20</td><td>5</td><td>40</td></tr><tr><td>LV mode share by 2051 (%)</td><td>75</td><td>65</td><td>55</td><td>40</td></tr><tr><td... | <table><tr><td>Outcome</td><td>RCN (monetized)</td></tr><tr><td>Cycling mode share by 2051 (%)</td><td>5</td></tr><tr><td>LV mode share by 2051 (%)</td><td>75</td></tr><tr><td>Proportion of people considering cycling always/mostly safe by 2040</td><td>0.4</td></tr><tr><td>LVKT (billion km)</td><td>–3.5</td></tr><tr><td... | <table><tr><td>ASBL (monetized)</td><td>SER (monetized)</td><td>ASBL + SER (monetized)</td></tr><tr><td>20</td><td>5</td><td>40</td></tr><tr><td>65</td><td>55</td><td>40</td></tr><tr><td>0.7</td><td>0.3</td><td>0.9</td></tr><tr><td>–7</td><td>–10</td><td>–18.5</td></tr><tr><td colspan="3"></td></tr><tr><td>360 (1,100)<... |
99faf7de717a3c898451b5a014e7817e23914e61571094256118fd37207b5a63.png | complex | <table><tr><td>Independent variables</td><td>β coefficient(Standardized β coefficient)</td><td>95% CI</td><td><i>p</i>-value</td></tr><tr><td>Age</td><td>0.061 (0.082)</td><td>- 0.101 – 0.222</td><td>0.461</td></tr><tr><td>BMI</td><td>1.509 (0.230)</td><td>1.056–1.961</td><td><i>< 0.001</i><sup... | <table><tr><td>Independent variables</td><td>β coefficient(Standardized β coefficient)</td><td>95% CI</td><td>p-value</td></tr><tr><td>Age</td><td>0.061 (0.082)</td><td>- 0.101 – 0.222</td><td>0.461</td></tr><tr><td>BMI</td><td>1.509 (0.230)</td><td>1.056–1.961</td><td>< 0.001†</td></tr><tr><td>Fasting</td><td></td><td... | <table><tr><td> blood glucose</td><td>0.044 (0.044)</td><td>– 0.131</td><td></td></tr><tr><td>Dyslipidemia (Yes vs. No)</td><td>- 1.014 (1.497)</td><td>- 3.961 – 1.934</td><td>0.499</td></tr><tr><td>High risk alcohol drinking habit (Yes vs. No)</td><td>- 0.851 (1.412)</td><td>- 3.630 – 1.929</td><td>0.547</td></tr><tr>... |
d1033a313e5d91d8587f2d128734387682b4e30081084bf5a069678cdcd969ad.png | complex | <table><tr><td></td><td>All</td><td colspan="3">Followed the advices</td><td colspan="3">Contacted GP</td><td colspan="3">Re-contact Casualty clinic</td></tr><tr><td></td><td>N = 100</td><td>YesN = 93</td><td>NoN = 7</td><td>p-value</td><td>YesN = 22</td><td>NoN = 78</td><td>p-value</td><td>YesN = 11</td><td>NoN = 89</... | <table><tr><td></td><td>All</td><td colspan="3">Followed the advices</td><td colspan="3">Contacted GP</td></tr><tr><td></td><td>N = 100</td><td>YesN = 93</td><td>NoN = 7</td><td>p-value</td><td>YesN = 22</td><td>NoN = 78</td><td>p-value</td></tr><tr><td>Origin of caller</td><td></td><td></td><td></td><td>0.08</td><td><... | <table><tr><td colspan="3">Re-contact Casualty clinic</td></tr><tr><td>YesN = 11</td><td>NoN = 89</td><td>p-value</td></tr><tr><td></td><td></td><td>> 0.99</td></tr><tr><td>10</td><td>74</td><td></td></tr><tr><td>1</td><td>15</td><td></td></tr><tr><td></td><td></td><td>0.07</td></tr><tr><td>5</td><td>17</td><td></td></... |
d909183fece0ad0682b89ea0bdb471baaca835592aeaac3cff31027268d1728b.png | simple | <table><tr><td>Protein Symbol</td><td>Protein Name</td><td>Organism</td><td>Function</td><td>Swiss Prot ID</td></tr><tr><td>OPN (SSP1)</td><td>Osteopontin, secreted phosphoprotein 1</td><td><i>Homo sapiens</i></td><td>Matrix mineralization, immunity</td><td>P10451</td></tr><tr><td>DMP1</td><td>Dentin matrix protein 1</... | <table><tr><td>Protein Symbol</td><td>Protein Name</td><td>Organism</td><td>Function</td><td>Swiss Prot ID</td></tr><tr><td>OPN (SSP1)</td><td>Osteopontin, secreted phosphoprotein 1</td><td>Homo sapiens</td><td>Matrix mineralization, immunity</td><td>P10451</td></tr><tr><td>DMP1</td><td>Dentin matrix protein 1</td><td>... | <table><tr><td>Protein Symbol</td><td>Protein Name</td><td>Organism</td><td>Function</td><td>Swiss Prot ID</td></tr><tr><td></td><td>rmaker</td><td>(zebrafish)</td><td>tion</td><td>VD23</td></tr><tr><td>OMM-64</td><td>Otolith matrix macromolecule-64</td><td>Oncorhynchus mykiss (rainbow trout)</td><td>Otolith formation<... |
18c1626fbc970126a013e8862893d3d71cf952273ba3a5ad87db2edd1d85fed0.png | simple | <table><tr><td>Question</td><td>Response rate (percentage; <i>n</i> = 86)</td></tr><tr><td>14. How did you usually use the video clips in PHARMACY 301?</td><td>79</td></tr><tr><td>15. How did watching the Pharmville clips help you in PHARMACY 301?</td><td>64</td></tr><tr><td>16. Which families are the most realistic an... | <table><tr><td>Question</td><td>Response rate (percentage; n = 86)</td></tr><tr><td>14. How did you usually use the video clips in PHARMACY 301?</td><td>79</td></tr><tr><td>15. How did watching the Pharmville clips help you in PHARMACY 301?</td><td>64</td></tr><tr><td>16. Which families are the most realistic and why?<... | <table><tr><td>Question</td><td>Response rate (percentage; n = 86)</td></tr><tr><td> do feel that Pharmville and the related clips helped your learning?</td><td>5</td></tr><tr><td>21. Space for any other comments about Pharmville that you would like to make.</td><td>17</td></tr></table> |
ab801841984517d68ca83a263b8151b2c89db486eb60b5b1834464e424235dee.png | complex | <table><tr><td rowspan="2">Runs order</td><td colspan="2">Operating conditions</td><td rowspan="2">Response Dry cell mass (g/l)</td></tr><tr><td>A</td><td>B</td></tr><tr><td>1</td><td>1</td><td>1</td><td>13.66 ± 0.08</td></tr><tr><td>2</td><td>0</td><td>1</td><td>14.96 ± 0.06</td></tr><tr><td>3</td><td>0</td>... | <table><tr><td rowspan="2">Runs order</td><td colspan="2">Operating conditions</td><td rowspan="2">Response Dry cell mass (g/l)</td></tr><tr><td>A</td><td>B</td></tr><tr><td>1</td><td>1</td><td>1</td><td>13.66 ± 0.08</td></tr><tr><td>2</td><td>0</td><td>1</td><td>14.96 ± 0.06</td></tr><tr><td>3</td><td>0</td><td>0</td>... | <table><tr><td rowspan="2">Runs order</td><td colspan="2">Operating conditions</td><td rowspan="2">Response Dry cell mass (g/l)</td></tr><tr><td>A</td><td>B</td></tr><tr><td>15</td><td></td><td>1</td><td></td></tr><tr><td>16</td><td>−1</td><td>0</td><td>16.17 ± 0.07</td></tr></table> |
2f9aa3bdcf898d7af7dbb841fa0ac941399b733e4d8cb053fc4ca866a8f43a13.png | simple | <table><tr><td>UHI Assessment TOOL</td><td>Geographical Cover</td><td>Scale of the Assessment</td><td>Type of Assessment</td><td>User Input Parameters</td><td>Tool Output</td></tr><tr><td>Decision Support System (DSS) UHI project</td><td>Bologna/Modena, Venice/Padua, Wien, Stuttgart, Lodz/Warsaw, Ljubljana, Budapest an... | <table><tr><td>UHI Assessment TOOL</td><td>Geographical Cover</td></tr><tr><td>Decision Support System (DSS) UHI project</td><td>Bologna/Modena, Venice/Padua, Wien, Stuttgart, Lodz/Warsaw, Ljubljana, Budapest and Prague.</td></tr><tr><td>CE Urban Heat Island Atlas UHI project</td><td>Central Europe region</td></tr><tr>... | <table><tr><td>Scale of the Assessment</td><td>Type of Assessment</td><td>User Input Parameters</td><td>Tool Output</td></tr><tr><td>Supra-metropolitan</td><td>Phase 1: Mapping Urban Heat. Phase 2: Understanding regulations and policies related to UHI (greenery: street or roof, material reflectance...)</td><td>1/Locati... |
4445e34c2dde6c6417996c914fafdadc9a23942fa22bee0d84c136025fc98822.png | complex | <table><tr><td>Item</td><td>SE</td><td>LE</td><td>SEM</td><td><i>P</i> value</td></tr><tr><td colspan="5">Sow BW (kg)</td></tr><tr><td> At insemination</td><td>72.7</td><td>72.9</td><td>0.9</td><td>0.840</td></tr><tr><td> At day 90 of pregnancy</td><td>127.9</td><td>117.0</td><td>1.9</td><td>0.002</td></tr><tr><td>Litt... | <table><tr><td>Item</td><td>SE</td><td>LE</td><td>SEM</td></tr><tr><td colspan="4">Sow BW (kg)</td></tr><tr><td>At insemination</td><td>72.7</td><td>72.9</td><td>0.9</td></tr><tr><td>At day 90 of pregnancy</td><td>127.9</td><td>117.0</td><td>1.9</td></tr><tr><td>Litter size</td><td>12.0</td><td>11.8</td><td>0.9</td></t... | <table><tr><td>P value</td></tr><tr><td>Sow BW (kg)</td></tr><tr><td>0.840</td></tr><tr><td>0.002</td></tr><tr><td>0.856</td></tr><tr><td>0.039</td></tr><tr><td>0.345</td></tr></table> |
dfdf9aec20d517508f2e751422c57e798d281f8c9c6c17a36ed98e53df10cb3f.png | complex | <table><tr><td>Pharmacological agents</td><td>Neonatal rat spinal cord preparation</td><td>Decerebrate cat preparation</td><td>Acute spinal cat</td><td>Early chronic spinal cat</td><td>Late chronic spinal cat</td><td>Late chronic spinal rat</td></tr><tr><td>Edrophonium (EDRO)</td><td rowspan="2">↑↑</td><td ... | <table><tr><td>Pharmacological agents</td><td>Neonatal rat spinal cord preparation</td><td>Decerebrate cat preparation</td><td>Acute spinal cat</td><td>Early chronic spinal cat</td><td>Late chronic spinal cat</td><td>Late chronic spinal rat</td></tr><tr><td>Edrophonium (EDRO)</td><td rowspan="2">↑↑</td><td rowspan="2">... | <table><tr><td>Pharmacological agents</td><td>Neonatal rat spinal cord preparation</td><td>Decerebrate cat preparation</td><td>Acute spinal cat</td><td>Early chronic spinal cat</td><td>Late chronic spinal cat</td><td>Late chronic spinal rat</td></tr><tr><td>NA agonist + muscarinic antagonist</td><td></td><td></td><td>↑... |
72472f5696f4038d9e964c1b24026b22442a24bea3c7412e4db364aae0b5aa88.png | simple | <table><tr><td>Samples with decreased expression (n)</td><td>Gene symbol</td><td>Mean log ratio</td><td>Range of log ratio</td><td>Samples with increased expression (n)</td><td>Mean log ratio</td><td>Range of log ratio</td></tr><tr><td>11</td><td>CD14</td><td>-2.99</td><td>-0.27/-5.38</td><td>0</td><td>-</td><td>-</td>... | <table><tr><td>Samples with decreased expression (n)</td><td>Gene symbol</td><td>Mean log ratio</td><td>Range of log ratio</td><td>Samples with increased expression (n)</td><td>Mean log ratio</td><td>Range of log ratio</td></tr><tr><td>11</td><td>CD14</td><td>-2.99</td><td>-0.27/-5.38</td><td>0</td><td>-</td><td>-</td>... | <table><tr><td>7</td><td>PDGFRB</td><td>-1.28</td><td>-0.61/-2.26</td><td>0</td><td>-</td><td>-</td></tr><tr><td>7</td><td>ATG5</td><td>-1.39</td><td>-0.61/-3.19</td><td>0</td><td>-</td><td>-</td></tr><tr><td>7</td><td>DOCK1</td><td>-0.86</td><td>-0.40/-1.23</td><td>0</td><td>-</td><td>-</td></tr><tr><td>7</td><td>PTPN... |
7ba81582c24aadeb91891f7aaef4c73d5108a4e8b72f133e3cde637a8756d58d.png | simple | <table><tr><td>Patient</td><td>Age</td><td>Site</td><td>Stage</td><td>Primary date</td><td>Primary therapy*</td><td>Recurrence</td><td>Expiry</td></tr><tr><td>1</td><td>50</td><td>Retromolar trigone</td><td>IV</td><td>2009/05/30</td><td>S+CCRT</td><td></td><td></td></tr><tr><td>2</td><td>55</td><td>Oral tongue</td><td>... | <table><tr><td>Patient</td><td>Age</td><td>Site</td><td>Stage</td><td>Primary date</td><td>Primary therapy*</td><td>Recurrence</td><td>Expiry</td></tr><tr><td>1</td><td>50</td><td>Retromolar trigone</td><td>IV</td><td>2009/05/30</td><td>S+CCRT</td><td></td><td></td></tr><tr><td>2</td><td>55</td><td>Oral tongue</td><td>... | <table><tr><td>Patient</td><td>Age</td><td>Site</td><td>Stage</td><td>Primary date</td><td>Primary therapy*</td><td>Recurrence</td><td>Expiry</td></tr><tr><td>5</td><td>49</td><td>Buccal mucosa</td><td>IV</td><td>2010/07/27</td><td>S+CCRT</td><td>2010/11/24</td><td>2011/06/07</td></tr><tr><td>6</td><td>48</td><td>Bucca... |
fc3299270282cb5f3774d5fa7f6966937e72512b4b20e69a2baa837f38054905.png | complex | <table><tr><td></td><td colspan="2">Acid fast bacilli</td><td>Total</td></tr><tr><td></td><td>negative for AFB</td><td>positive for AFB</td><td></td></tr><tr><td>Giant cells</td><td></td><td></td><td></td></tr><tr><td> Not present</td><td>50</td><td>25</td><td>75</td></tr><tr><td> Present</td><td>6</td><td>19</td><td>2... | <table><tr><td></td><td colspan="2">Acid fast bacilli</td><td>Total</td></tr><tr><td></td><td>negative for AFB</td><td>positive for AFB</td><td></td></tr><tr><td>Giant cells</td><td></td><td></td><td></td></tr><tr><td>Not present</td><td>50</td><td>25</td><td>75</td></tr></table> | <table><tr><td></td><td colspan="2">Acid fast bacilli</td><td>Total</td></tr><tr><td></td><td>negative for AFB</td><td>positive for AFB</td><td></td></tr><tr><td>Present</td><td>6</td><td>19</td><td>25</td></tr><tr><td>Total</td><td>56</td><td>44</td><td>100</td></tr></table> |
bb216bed9e7d1f0d8c98e4853b62f93535044ee30e87d123baa46d362861cd61.png | simple | <table><tr><td>Parameters</td><td>≤5 (<i>n</i> = 92)</td><td>6–15 (<i>n</i> = 26)</td><td>≥16 (<i>n</i> = 18)</td><td><i>P</i> value</td></tr><tr><td>TAC, g/dL</td><td>2.37 ± 0.57</td><td>2.55 ± 0.43</td><td>2.71 ± 39</td><td>0.025</td></tr><tr><td>MDA, <i>μ</i>mol/L</td><td>3.74 &... | <table><tr><td>Parameters</td></tr><tr><td>TAC, g/dL</td></tr><tr><td>MDA, μmol/L</td></tr><tr><td>BMI, kg/m2</td></tr></table> | <table><tr><td>≤5 (n = 92)</td><td>6–15 (n = 26)</td><td>≥16 (n = 18)</td><td>P value</td></tr><tr><td>2.37 ± 0.57</td><td>2.55 ± 0.43</td><td>2.71 ± 39</td><td>0.025</td></tr><tr><td>3.74 ± 1.11</td><td>3.82 ± 1.18</td><td>3.50 ± 0.88</td><td>0.60</td></tr><tr><td>24.46 ± 3.80</td><td>26.06 ± 3.34</td><td>25.61 ± 2.88... |
161cbac47ac7f617014a1cef53e78739f70a72b602ab45cdac36cdf6baf473f6.png | simple | <table><tr><td>Parameter</td><td>P-value</td></tr><tr><td>Region</td><td>0.027</td></tr><tr><td>Age</td><td>0.103</td></tr><tr><td>Gender</td><td>0.168</td></tr><tr><td>Histology</td><td>0.906</td></tr><tr><td>Stage</td><td>0.901</td></tr><tr><td>Smoking status</td><td>0.668</td></tr><tr><td>Diabetes mellitus</td><td>0... | <table><tr><td>Parameter</td><td>P-value</td></tr><tr><td>Region</td><td>0.027</td></tr></table> | <table><tr><td>Parameter</td><td>P-value</td></tr><tr><td>Age</td><td>0.103</td></tr><tr><td>Gender</td><td>0.168</td></tr><tr><td>Histology</td><td>0.906</td></tr><tr><td>Stage</td><td>0.901</td></tr><tr><td>Smoking status</td><td>0.668</td></tr><tr><td>Diabetes mellitus</td><td>0.142</td></tr></table> |
0e6eada3e9b98021118d71adeacf1cfae78abef80c3eaf01a32b83c01e001308.png | complex | <table><tr><td></td><td>β-coefficient</td><td>OR</td><td>95% CI</td><td><i>p</i>-value</td></tr><tr><td colspan="5">Measurements at sea level (after variable selection)</td></tr><tr><td>age</td><td>0.075</td><td>1.08</td><td>0.99–1.18</td><td>0.092</td></tr><tr><td>BUN</td><td>−0.259</td><td>0.77</td><... | <table><tr><td></td><td>β-coefficient</td><td>OR</td><td>95% CI</td><td>p-value</td></tr><tr><td colspan="5">Measurements at sea level (after varia</td></tr></table> | <table><tr><td></td><td>β-coefficient</td><td>OR</td><td>95% CI</td><td>p-value</td></tr><tr><td colspan="5">ble selection)</td></tr><tr><td>age</td><td>0.075</td><td>1.08</td><td>0.99–1.18</td><td>0.092</td></tr><tr><td>BUN</td><td>−0.259</td><td>0.77</td><td>0.60–0.99</td><td>0.040*</td></tr><tr><td colspan="5">Measu... |
7565c7f6961ec760e151806e32f9c86f2d2495b3041be4b9ea4b7228d7501ef7.png | simple | <table><tr><td></td><td>OR</td><td>95% CI</td><td><i>P</i>-value</td></tr><tr><td><i>Ser/Ser</i> vs. <i>Asn/Asn</i></td><td>5.68</td><td>4.83–6.70</td><td>< 0.0001</td></tr><tr><td><i>Ser/Ser</i> vs. <i>Asn/Ser</i></td><td>4.93</td><td>4.28–5.68</td><td>< 0.0001</td></tr><tr><td><i>Ser/Ser</i> vs. <i>... | <table><tr><td></td><td>OR</td><td>95% CI</td></tr><tr><td>Ser/Ser vs. Asn/Asn</td><td>5.68</td><td>4.83–6.70</td></tr><tr><td>Ser/Ser vs. Asn/Ser</td><td>4.93</td><td>4.28–5.68</td></tr><tr><td>Ser/Ser vs. Asn/Asn + Asn/Ser</td><td>5.21</td><td>4.65–5.85</td></tr></table> | <table><tr><td>P-value</td></tr><tr><td>< 0.0001</td></tr><tr><td>< 0.0001</td></tr><tr><td>< 0.0001</td></tr></table> |
50334f82dfe4e125176077c21f85b5c2ac4a5ce5fa066230c1b56c9760f7d852.png | complex | <table><tr><td></td><td colspan="2">Pneumonia (n=5709)</td></tr><tr><td></td><td>Without rickets</td><td>With rickets</td></tr><tr><td></td><td>n=5600</td><td>n=109</td></tr><tr><td>Deaths n (%)</td><td>345 (6.16)</td><td>9 (8.26)</td></tr><tr><td><i>Odds-ratio</i></td><td colspan="2"><i>1.37 (p-value = 0.32)</i></td><... | <table><tr><td></td><td colspan="2">Pneumonia (n=5709)</td></tr><tr><td></td><td>Without rickets</td><td>With rickets</td></tr><tr><td></td><td>n=5600</td><td>n=109</td></tr><tr><td>Deaths n (%)</td><td>345 (6.16)</td><td>9 (8.26)</td></tr><tr><td>Odds-ratio</td><td colspan="2">1.37 (p-value = 0.32)</td></tr><tr><td></... | <table><tr><td></td><td>ut rickets</td><td>ts</td></tr><tr><td></td><td>n=2180</td><td>n=53</td></tr><tr><td>Deaths n (%)</td><td>230 (10.55)</td><td>4 (7.55)</td></tr><tr><td>Odds-ratio</td><td colspan="2">0.69 (p-value = 0.65)</td></tr><tr><td></td><td colspan="2">Diarrhea, n=2805</td></tr><tr><td></td><td>Without Ri... |
d856948bd4a18d91c2b128894fd29a54b57a83691ad31cface15bbaaa2b96b34.png | simple | <table><tr><td>State</td><td>NE level</td><td>I<sub>h</sub></td><td>Apical function</td></tr><tr><td>Asleep</td><td>Low</td><td>High</td><td>Isolated from soma</td></tr><tr><td>Awake</td><td>Moderate</td><td>Moderate</td><td>Selective amplification</td></tr><tr><td>Attentive</td><td>High</td><td>Low</td><td>Inc. Select... | <table><tr><td>State</td><td>NE level</td><td>Ih</td><td>Apical function</td><td rowspan="2"></td></tr><tr><td>Asleep</td><td>Low</td><td>High</td><td>Isolated from soma</td></tr></table> | <table><tr><td>Awake</td><td>Moderate</td><td>Moderate</td><td>Selective amplification</td><td rowspan="2"></td></tr><tr><td>Attentive</td><td>High</td><td>Low</td><td>Inc. Selectivity & Amplif.</td></tr><tr><td>High arousal</td><td>Maximum</td><td>Minimum</td><td>Selective drive e.g., Stereotypical impulses</td><td></... |
9bebc6c8cb5168fc18c705e333b8c9b5bfe811c0d8449be107e5b75abc10d973.png | complex | <table><tr><td></td><td></td><td></td><td colspan="5">Relative Normalised Expression</td></tr><tr><td>Receptor Class</td><td>Accession Number</td><td>Gene Name</td><td colspan="3">BMM</td><td colspan="2">TEPM</td></tr><tr><td></td><td></td><td></td><td>2 h</td><td>6 h</td><td>24 h</td><td>1 h</td><td>7 h</td></tr><tr><... | <table><tr><td></td><td></td><td></td><td colspan="5">Relative Normalised Expression</td></tr><tr><td>Receptor Class</td><td>Accession Number</td><td>Gene Name</td><td colspan="3">BMM</td><td colspan="2">TEPM</td></tr><tr><td></td><td></td><td></td><td>2 h</td><td>6 h</td><td>24 h</td><td>1 h</td><td>7 h</td></tr><tr><... | <table><tr><td></td><td>022320</td><td>35</td><td>.2</td><td>0.4</td><td>6</td><td>0.6</td><td>0.1</td></tr><tr><td></td><td>NM_030258</td><td>Gpr146</td><td>0.1</td><td>0.4</td><td>1.0</td><td>0.4</td><td>0.1</td></tr><tr><td></td><td>NM_008772</td><td>P2ry1</td><td>0.3</td><td>0.1</td><td>0.2</td><td>0.3</td><td>0.1<... |
6b5397669cff38bf5f54dbdff8f0b5e180c5e4255de1eb970bcee7ba9e0f9907.png | complex | <table><tr><td colspan="5">Presence of IFG</td></tr><tr><td>Characteristics</td><td>Yes (%)</td><td>N (%)</td><td>COR</td><td>AOR</td></tr><tr><td colspan="5">Age</td></tr><tr><td>< 25</td><td>7 (2.0)</td><td>336 (98.0)</td><td>1.0</td><td>1.0</td></tr><tr><td> 25–34</td><td>28 (7.7)</td><td>334 (92.3)</td><td... | <table><tr><td colspan="5">Presence of IFG</td></tr><tr><td>Characteristics</td><td>Yes (%)</td><td>N (%)</td><td>COR</td><td>AOR</td></tr><tr><td colspan="5">Age</td></tr><tr><td>< 25</td><td>7 (2.0)</td><td>336 (98.0)</td><td>1.0</td><td>1.0</td></tr><tr><td>25–34</td><td>28 (7.7)</td><td>334 (92.3)</td><td>4.0 (1.7–... | <table><tr><td colspan="5">Current alcohol consumption</td></tr><tr><td>Yes</td><td>91 (13.9)</td><td>565 (86.1)</td><td>1.5 (0.2–11.6)</td><td>0.8 (0.4–1.4)</td></tr><tr><td>No</td><td>1 (10.0)</td><td>9 (90.0)</td><td>1.0</td><td>1.0</td></tr><tr><td colspan="5">Physical activity</td></tr><tr><td>Vigorous</td><td>20 ... |
40d9274345459fb00befd198c932e34d3714ce7d1a55994b74d8c1506402f12c.png | simple | <table><tr><td></td><td>V1</td><td>V2</td><td>V3</td><td>V4</td></tr><tr><td>V1</td><td>1.00 (69)</td><td>0.37 (69)**</td><td>0.07 (69)</td><td>0.08 (69)</td></tr><tr><td></td><td>1.00 (165)</td><td>0.35 (109)**</td><td>0.10 (96)</td><td>0.24 (89)*</td></tr><tr><td>V2</td><td></td><td>1.00 (69)</td><td>0.21 (69)</td><t... | <table><tr><td></td><td>V1</td><td>V2</td><td>V3</td><td>V4</td></tr><tr><td>V1</td><td>1.00 (69)</td><td>0.37 (69)**</td><td>0.07 (69)</td><td>0.08 (69)</td></tr><tr><td></td><td>1.00 (165)</td><td>0.35 (109)**</td><td>0.10 (96)</td><td>0.24 (89)*</td></tr><tr><td>V2</td><td></td><td>1.00 (69)</td><td>0.21 (69)</td><t... | <table><tr><td></td><td>V1</td><td>V2</td><td>V3</td><td>V4</td></tr><tr><td>V4</td><td></td><td></td><td></td><td>1.00 (69)</td></tr><tr><td></td><td></td><td></td><td></td><td>1.00 (105)</td></tr></table> |
ddd547cac72d797fa3c07fc9d41c9bf867349874f494746e07582981af2f8a61.png | simple | <table><tr><td></td><td>Mean</td><td>SD</td><td>Maximum</td><td>Minimum</td></tr><tr><td>Maximum level of low back pain in the past year</td><td>8.81</td><td>1.13</td><td>10</td><td>7</td></tr><tr><td>Number of days without pain in the past year</td><td>37.04</td><td>51.82</td><td>174</td><td>0</td></tr><tr><td>Number ... | <table><tr><td></td><td>Mean</td><td>SD</td><td>Maximum</td><td>Minimum</td></tr><tr><td>Maximum l</td><td>8</td><td>1</td><td></td><td>7</td></tr></table> | <table><tr><td></td><td>Mean</td><td>SD</td><td>Maximum</td><td>Minimum</td></tr><tr><td>evel of low back pain in the past year</td><td>.81</td><td>.13</td><td>10</td><td></td></tr><tr><td>Number of days without pain in the past year</td><td>37.04</td><td>51.82</td><td>174</td><td>0</td></tr><tr><td>Number of days with... |
4b44e2eeeb006a698ec59dfb9c62466d04ad6eaf27c194255702942c837ef6ed.png | complex | <table><tr><td rowspan="2">Clinical Factors</td><td colspan="3">No. of patients (%)</td><td rowspan="2">P value <sup>b</sup></td><td colspan="3">No. of patients (%)</td></tr><tr><td>Total</td><td>Low MTV <sup>a</sup></td><td>High MTV <sup>a</sup></td><td>Low TLG <sup>a</sup></td><td>High TLG <sup>a</sup></td><td>P valu... | <table><tr><td rowspan="2">Clinical Factors</td><td colspan="3">No. of patients (%)</td><td rowspan="2">P value b</td><td colspan="3">No. of patients (%)</td></tr><tr><td>Total</td><td>Low MTV a</td><td>High MTV a</td><td>Low TLG a</td><td>High TLG a</td><td>P value b</td></tr><tr><td>Age</td><td></td><td></td><td></td... | <table><tr><td rowspan="2">Clinical Factors</td><td colspan="3">No. of patients (%)</td><td rowspan="2">P value b</td><td colspan="3">No. of patients (%)</td></tr><tr><td>Total</td><td>Low MTV a</td><td>High MTV a</td><td>Low TLG a</td><td>High TLG a</td><td>P value b</td></tr><tr><td>0-1</td><td>55</td><td>32(70)</td>... |
4d38196e43591fd25440c72362c9ca11cec5b82b5741d43b876e556da50121f1.png | simple | <table><tr><td>Country</td><td>2012</td><td>2013</td><td>2014</td><td>2015</td><td>2016</td><td>2017</td><td>2018</td></tr><tr><td>Angola</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Country</td><td>2 267 799</td><td>6 933 500</td><td>9 536 500</td><td>17 327 500</td><td>25 494 500</t... | <table><tr><td>Country</td><td>2012</td><td>2013</td><td>2014</td><td>2015</td><td>2016</td><td>2017</td><td>2018</td></tr><tr><td>Angola</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Country</td><td>2 267 799</td><td>6 933 500</td><td>9 536 500</td><td>17 327 500</td><td>25 494 500</t... | <table><tr><td>Country</td><td>2012</td><td>2013</td><td>2014</td><td>2015</td><td>2016</td><td>2017</td><td>2018</td></tr><tr><td>ry</td><td>—</td><td>2 088 500</td><td>1 787 500</td><td>765 500</td><td> 500</td><td>00</td><td>14 500</td></tr><tr><td>GAVI</td><td>—</td><td>10 024 000</td><td>23 931 500</td><td>13 843 ... |
96a035a64fa3b71b4969a2ca3a40014ca0ebb56eab686082d2e4276f75e230c2.png | simple | <table><tr><td>Pathogen</td><td>Number of patients</td><td>Gender (male/female) </td><td>Median age (min–max)</td><td>Mortality (%) (survivors/death)</td></tr><tr><td><i>S. pneumoniae </i></td><td>14</td><td>5/8<sup>1</sup></td><td>5.5 (0–40)</td><td>46% (7/6)<sup>1</sup></td></tr><tr><td><i>N. meningitidis... | <table><tr><td>Pathogen</td><td>Number of patients</td><td>Gender (male/female)</td><td>Median age (min–max)</td></tr><tr><td>S. pneumoniae</td><td>14</td><td>5/81</td><td>5.5 (0–40)</td></tr><tr><td>N. meningitidis</td><td>22</td><td>10/92</td><td>5.5 (1–60)</td></tr><tr><td>H. influenzae</td><td>9</td><td>7/2</td><td... | <table><tr><td>Mortality (%) (survivors/death)</td></tr><tr><td>46% (7/6)1</td></tr><tr><td>27% (16/6)</td></tr><tr><td>0% (9/0)</td></tr></table> |
bb5b5e2b780a56f6087e9af78ca43b9744d916a0fd7b16f58c30170d616ca862.png | simple | <table><tr><td>Author</td><td>Derivation sample</td><td>Validation sample</td><td>Predictors</td><td>Outcomes</td><td>Performance in the validation sample</td><td>Presentation of a simplified score</td></tr><tr><td>Pillai et al.</td><td>208 patients from India with severe TBI</td><td>26 patients from the same centre</t... | <table><tr><td>Author</td><td>Derivation sample</td><td>Validation sample</td><td>Predictors</td><td>Outcomes</td><td>Performance in the validation sample</td><td>Presentation of a simplified score</td></tr><tr><td>Pillai et al.</td><td>208 patients from India with severe TBI</td><td>26 patients from the same centre</t... | <table><tr><td>Author</td><td>Derivation sample</td><td>Validation sample</td><td>Predictors</td><td>Outcomes</td><td>Performance in the validation sample</td><td>Presentation of a simplified score</td></tr><tr><td>Hukkelhoven et al.</td><td>2269 patients from 2 trials in high income countries with moderate and severe ... |
5418b4230b01ae77d9ff07987060b6ddc9acd71b0a4ae9aebf06a62fc78cc0a7.png | simple | <table><tr><td>Rank</td><td>Feature name</td><td>Mean SP</td><td>Mean ME</td><td>P-value</td><td>Rank</td><td>Feature name</td><td>Mean SP</td><td>Mean ME</td><td>P-value</td></tr><tr><td>1</td><td>Degree</td><td>36.6</td><td>86.9</td><td>2.8e-106</td><td>21</td><td>42</td><td>0.00631</td><td>0.0108</td><td>8.2e-45</td... | <table><tr><td>Rank</td><td>Feature name</td><td>Mean SP</td><td>Mean ME</td><td>P-value</td><td>Rank</td><td>Feature name</td><td>Mean SP</td><td>Mean ME</td><td>P-value</td></tr><tr><td>1</td><td>Degree</td><td>36.6</td><td>86.9</td><td>2.8e-106</td><td>21</td><td>42</td><td>0.00631</td><td>0.0108</td><td>8.2e-45</td... | <table><tr><td>Rank</td><td>Feature name</td><td>Mean SP</td><td>Mean ME</td><td>P-value</td><td>Rank</td><td>Feature name</td><td>Mean SP</td><td>Mean ME</td><td>P-value</td></tr><tr><td>4</td><td>45</td><td>0.006</td><td>0.0113</td><td>5.2e-82</td><td>24</td><td>10</td><td>0.00372</td><td>0.00619</td><td>1.5e-43</td>... |
d79bbfdaf3c7c8c8dab23c2db5df81ca91924e4635105683022dbb7f21e1b34e.png | simple | <table><tr><td> </td><td>Mild TBI</td><td>Moderate TBI</td><td>Severe TBI</td><td>p-value</td></tr><tr><td>Number of patients</td><td>229</td><td>85</td><td>54</td><td>-</td></tr><tr><td>Age at time of injury (years)</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Mean ± standard deviation</td><td>23.7 &#... | <table><tr><td></td><td>Mild TBI</td><td>Moderate TBI</td><td>Severe TBI</td><td>p-value</td></tr><tr><td>Number of patients</td><td>229</td><td>85</td><td>54</td><td>-</td></tr><tr><td>Age at time of injury (years)</td><td></td><td></td><td></td><td></td></tr><tr><td>Mean ± standard deviation</td><td>23.7 ± 16.6</td><... | <table><tr><td></td><td>Mild TBI</td><td>Moderate TBI</td><td>Severe TBI</td><td>p-value</td></tr><tr><td>Number of patients</td><td>229</td><td>85</td><td>54</td><td>-</td></tr><tr><td>minimum - maximum)</td><td>.0</td><td>76.0</td><td>.0</td><td></td></tr><tr><td>median</td><td>20.0</td><td>28.0</td><td>19.0</td><td>... |
80b1d592b442dc42dd3f5b72343857a7d59664c062171d14ba891d9d7dd83bca.png | simple | <table><tr><td>Variable</td><td>Case (n=127)</td><td>Control (127)</td></tr><tr><td> </td><td>Number (%)</td><td>Number (%)</td></tr><tr><td>Ethnicity</td><td> </td><td> </td></tr><tr><td>Oromo</td><td>122(96.1)</td><td>123(96.9)</td></tr><tr><td>Others</td><td>5(3.9)</td><td>4(3.1)</td></tr><tr><td>Religion</td><td> <... | <table><tr><td>Variable</td><td>Case (n=127)</td><td>Control (127)</td></tr><tr><td></td><td>Number (%)</td><td>Number (%)</td></tr><tr><td>Ethnicity</td><td></td><td></td></tr><tr><td>Oromo</td><td>122(96.1)</td><td>123(96.9)</td></tr><tr><td>Others</td><td>5(3.9)</td><td>4(3.1)</td></tr><tr><td>Religion</td><td></td>... | <table><tr><td>20-34</td><td>85(66.9)</td><td>98(77.2)</td></tr><tr><td>≥35</td><td>37(29.2)</td><td>26(20.4)</td></tr><tr><td>Marital status</td><td></td><td></td></tr><tr><td>Married</td><td>121(95.3)</td><td>126(99.2)</td></tr><tr><td>Widowed</td><td>6(4.7)</td><td>1(0.8)</td></tr><tr><td>Sex of infants</td><td></td... |
d7f040fbd3b5c11441c93635d70fe654b291636d6cf8fc8311daefa8726fda3c.png | simple | <table><tr><td>Variables</td><td>Cupping<i>n</i> = 30</td><td>Resting<i>n</i> = 30</td><td><i>P</i></td></tr><tr><td>Gender (%)</td><td> </td><td> </td><td>0.640</td></tr><tr><td> Male</td><td>3 (10.0)</td><td>2 (6.7)</td><td> </td></tr><tr><td> Female</td><td>27 (90.0)</td><td>28 (93.3)</td><td> </td></tr><tr><td>Age ... | <table><tr><td>Variables</td><td>Cuppingn = 30</td><td>Restingn = 30</td></tr><tr><td>Gender (%)</td><td></td><td></td></tr><tr><td>Male</td><td>3 (10.0)</td><td>2 (6.7)</td></tr><tr><td>Female</td><td>27 (90.0)</td><td>28 (93.3)</td></tr><tr><td>Age (mean ± SD)</td><td>43.6 ± 8.0</td><td>42.5 ± 7.4</td></tr></table> | <table><tr><td>P</td></tr><tr><td>0.640</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>0.486</td></tr></table> |
63eff125664ac9e982bbda705cde8c6ce1cdbd9a799e5fca97fe917be81d84dd.png | simple | <table><tr><td>Method</td><td>MDR</td><td>AntEpiSeeker</td><td>BOOST</td><td>MegaSNPHunter</td><td>KNN-MDR</td></tr><tr><td>Power</td><td>N/A</td><td>0.65</td><td>0.67</td><td>0.80</td><td>0.74</td></tr><tr><td>Corrected power</td><td>N/A</td><td>0.15</td><td>0.28</td><td>0.12</td><td>0.63</td></tr></table> | <table><tr><td>Method</td><td>MDR</td><td>AntEpiSeeker</td><td>BOOST</td><td>MegaSNPHunter</td></tr><tr><td>Power</td><td>N/A</td><td>0.65</td><td>0.67</td><td>0.80</td></tr><tr><td>Corrected power</td><td>N/A</td><td>0.15</td><td>0.28</td><td>0.12</td></tr></table> | <table><tr><td>KNN-MDR</td></tr><tr><td>0.74</td></tr><tr><td>0.63</td></tr></table> |
8bdfbaa0789f10cf1d4d468f3eb694ad8f26d84d5357b949927abdc313bd1e18.png | complex | <table><tr><td>Patient</td><td colspan="4">HAX-1</td><td>ER</td></tr><tr><td></td><td colspan="2">Normal</td><td colspan="2">Tumor</td><td>Tumor</td></tr><tr><td></td><td>Cytoplasm</td><td>Nucleus</td><td>Cytoplasm</td><td>Nucleus</td><td>Nucleus</td></tr><tr><td>1</td><td>0</td><td>-</td><td>2</td><td>-</td><td>+</td>... | <table><tr><td>Patient</td><td colspan="3">HAX-1</td></tr><tr><td></td><td colspan="2">Normal</td><td>Tumor</td></tr><tr><td></td><td>Cytoplasm</td><td>Nucleus</td><td>Cytoplasm</td></tr><tr><td>1</td><td>0</td><td>-</td><td>2</td></tr><tr><td>2</td><td>0/1</td><td>-</td><td>1</td></tr><tr><td>3</td><td>1</td><td>-</td... | <table><tr><td>HAX-1</td><td>ER</td></tr><tr><td>Tumor</td><td>Tumor</td></tr><tr><td>Nucleus</td><td>Nucleus</td></tr><tr><td>-</td><td>+</td></tr><tr><td>-</td><td>-</td></tr><tr><td>-</td><td>-</td></tr><tr><td>-</td><td>-</td></tr><tr><td>-</td><td>-</td></tr><tr><td>-</td><td>-</td></tr><tr><td>+</td><td>+</td></t... |
1a0c56ad2f3f0df193b17cd684516c8d3c04cfda90ed85fe03c550c494fbb12c.png | complex | <table><tr><td rowspan="2">Ricketts analysis</td><td colspan="3">Pretreatment (16 years, 4 months)</td><td colspan="3">Posttreatment (19 years, 8 months)</td></tr><tr><td>Norm</td><td>Value</td><td>Deviation</td><td>Norm</td><td>Value</td><td>Deviation</td></tr><tr><td colspan="7">Cranial relations</td></tr><tr><td> Fa... | <table><tr><td rowspan="2">Ricketts analysis</td><td>Pretreatment (16 years, 4 months)</td></tr><tr><td>Norm</td></tr><tr><td colspan="2">Cranial relations</td></tr><tr><td>Facial axis (°)</td><td>90 ± 3.5</td></tr><tr><td>Mandibular plane (°)</td><td>23.6 ± 4</td></tr><tr><td>Mandibular arc (°)</td><td>26 ± 4</td></tr... | <table><tr><td colspan="2">Pretreatment (16 years, 4 months)</td><td colspan="3">Posttreatment (19 years, 8 months)</td></tr><tr><td>Value</td><td>Deviation</td><td>Norm</td><td>Value</td><td>Deviation</td></tr><tr><td colspan="5">Cranial relations</td></tr><tr><td>88.4</td><td rowspan="4">vertical growth type</td><td>... |
7b3d1e4ee81d516256fbc5c510f52b918cb88d8b3010367af94e87310afa7fee.png | complex | <table><tr><td>Author</td><td>Year, Country</td><td rowspan="2">Investigation period</td><td rowspan="2">No. of colic cases</td><td colspan="2">Distribution of cases</td><td colspan="4">Cases euthanized or dead %</td><td colspan="3">Short-term survival rates (%)</td></tr><tr><td colspan="2"> </td><td>Medical %</td><td>... | <table><tr><td>Author</td><td>Year, Country</td><td rowspan="2">Investigation period</td><td rowspan="2">No. of colic cases</td><td colspan="2">Distribution of cases</td><td colspan="4">Cases euthanized or dead %</td><td colspan="3">Short-term survival rates (%)</td></tr><tr><td colspan="2"></td><td>Medical %</td><td>S... | <table><tr><td>Author</td><td>Year, Country</td><td rowspan="2">Investigation period</td><td rowspan="2">No. of colic cases</td><td colspan="2">Distribution of cases</td><td colspan="4">Cases euthanized or dead %</td><td colspan="3">Short-term survival rates (%)</td></tr><tr><td colspan="2"></td><td>Medical %</td><td>S... |
121a48c5bb2753a4b436324012f024bc01aeb69a511876b224f0b7dd0d17c04f.png | complex | <table><tr><td rowspan="2">Place, author's and years of Examination</td><td colspan="2">Prevalence of schistosomiasis</td></tr><tr><td><i>Schistosoma haematobium</i> %</td><td><i>Schistosoma mansoni</i> %</td></tr><tr><td colspan="3">This study</td></tr><tr><td>Before mass treatment 2002</td><td>13.6</td><td>36.3</td><... | <table><tr><td rowspan="2">Place, author's and years of Examination</td><td colspan="2">Prevalence of schistosomiasis</td></tr><tr><td>Schistosoma haematobium %</td><td>Schistosoma mansoni %</td></tr><tr><td colspan="3">This study</td></tr><tr><td>Before mass treatment 2002</td><td>13.6</td><td>36.3</td></tr><tr><td>Af... | <table><tr><td rowspan="2">Place, author's and years of Examination</td><td colspan="2">Prevalence of schistosomiasis</td></tr><tr><td>Schistosoma haematobium %</td><td>Schistosoma mansoni %</td></tr><tr><td>Before mass treatment (1989)</td><td>25.7</td><td>7.4</td></tr><tr><td>After mass treatment (2006)</td><td>38.3<... |
850578d392ae27ee86f62c979e359584302852b5d7dc34db33bc45f3272638cc.png | complex | <table><tr><td rowspan="3">into</td><td colspan="5">from</td></tr><tr><td>AG-T</td><td>MEX</td><td>SA1</td><td>SA2</td><td>USA</td></tr><tr><td>AG-T</td><td>99 (96.4–100)</td><td>0.3 (0–1.6)</td><td>0.3 (0–1.7)</td><td>0.3 (0–1.6)</td><td>0.2 (0–1.7)</td></tr><tr><td>MEX</td><td>0 (0–... | <table><tr><td rowspan="3">into</td><td colspan="5">from</td></tr><tr><td>AG-T</td><td>MEX</td><td>SA1</td><td>SA2</td><td>USA</td></tr><tr><td colspan="5"></td></tr><tr><td>AG-T</td><td>99 (96.4–100)</td><td>0.3 (0–1.6)</td><td>0.3 (0–1.7)</td><td>0.3 (0–1.6)</td><td>0.2 (0–1.7)</td></tr><tr><td>MEX</td><td>0 (0–0.2)<... | <table><tr><td>SA2</td><td>0 (0–0.4)</td><td>0.1 (0–0.6)</td><td>0.3 (0–1.5)</td><td>99.2 (97.7–100)</td><td>0.3 (0–1.1)</td></tr><tr><td>USA</td><td>0 (0–0.1)</td><td>0 (0–0.2)</td><td>0 (0–0.2)</td><td>0 (0–0.2)</td><td>99.9 (99.6–100)</td></tr></table> |
97554ee2302cf487726a533e57a4527ec1e366629ec31d74f0ed50e16c8713c3.png | simple | <table><tr><td>Cigarettes: ‘surgeon general’s warning’</td><td>Smokeless tobacco: ‘warning’</td></tr><tr><td>Smoking causes lung cancer, heart disease, emphysema, and may complicate pregnancy</td><td>This product may cause mouth cancer</td></tr><tr><td>Quitting smoking now greatly reduces ... | <table><tr><td>Cigarettes: ‘surgeon general’s warning’</td><td>Smokeless tobacco: ‘warning’</td></tr><tr><td>Smoking causes lung cancer, heart disease, emphysema, and may complicate pregnancy</td><td>This product may cause mouth cancer</td></tr><tr><td>Quitting smoking now greatly reduces serious risks to your health</... | <table><tr><td>Smoking by pregnant women may result in fetal injury, premature birth, and low birth weight</td><td>Proposed: this product contains nicotine and is addictive</td></tr><tr><td>Cigarette smoke contains carbon monoxide</td><td>Compromise: this product is not a safe alternative to cigarettes</td></tr></table... |
767f0d68a4436b33ef57ea5c42fc2a44d9e625c3375279d66e81fe3621564790.png | complex | <table><tr><td colspan="2">Variable</td><td>>18.50</td><td>18.50–24.99</td><td>25.0–29.99</td><td>≥30</td><td rowspan="2"><i>p</i> Value</td></tr><tr><td></td><td></td><td>(<i>n</i> = 141)</td><td>(<i>n</i> = 1164)</td><td>(<i>n</i> = 225)</td><td>(<i>n</i> = 72)</td></tr><tr><td colspan="2">Durati... | <table><tr><td colspan="2">Variable</td><td>>18.50</td><td>18.50–24.99</td><td>25.0–29.99</td><td>≥30</td><td rowspan="2">p Value</td></tr><tr><td></td><td></td><td>(n = 141)</td><td>(n = 1164)</td><td>(n = 225)</td><td>(n = 72)</td></tr><tr><td colspan="2">Duration of stimulation (d)</td><td>10.35 ± 2.17</td><td>10.01... | <table><tr><td colspan="2">ICSI (%)</td><td>110/129 (85.3%)</td><td>902/1066 (84.6%)</td><td>181/205 (88.3%)</td><td>56/62 (90.3%)</td><td>0.37</td></tr><tr><td colspan="2">Fertilization rate (%)</td><td>68.05 ± 28.61</td><td>67.22 ± 27.12</td><td>66.34 ± 29.47</td><td>60.98 ± 28.49</td><td>0.35</td></tr><tr><td colspa... |
22423437329823591e8a7e6e415ad67c9d6ce6f112b7958a3512eda569d61d0f.png | simple | <table><tr><td>Primer Name</td><td>Sequence</td><td>Gene</td></tr><tr><td>CSnmrAF</td><td>AGTAGGGTAGGCAGCATCCA</td><td>Check for PC-06 (NmrA)</td></tr><tr><td>CSnmrAR</td><td>GCGCACTATTTCTGAGCAGC</td><td>Check for PC-06</td></tr><tr><td>pen1</td><td>ATGTCCAGATCCCTAACCCAC</td><td>Screen for penP deletion</td></tr><tr><t... | <table><tr><td>Primer Name</td><td>Sequence</td><td>Gene</td></tr><tr><td>CSnmrAF</td><td>AGTAGGGTAGGCAGCATCCA</td><td>Check for PC-06 (NmrA)</td></tr><tr><td>CSnmrAR</td><td>GCGCACTATTTCTGAGCAGC</td><td>Check for PC-06</td></tr><tr><td>pen1</td><td>ATGTCCAGATCCCTAACCCAC</td><td>Screen for penP deletion</td></tr><tr><t... | <table><tr><td>Primer Name</td><td>Sequence</td><td>Gene</td></tr><tr><td>SFADF</td><td>TCCTCGTGCCCTTGACAT</td><td> for janO (FAD)</td></tr><tr><td>CSFADR</td><td>GACCATGCTGTACCGAACGT</td><td>Check for janO (FAD)</td></tr></table> |
e359a11f03731c303bfd1b1a5705b4833b9265383ca0a8a6098be53a3545ea16.png | simple | <table><tr><td>Translocation</td><td>Translocation partner</td><td>ATRA response</td></tr><tr><td>t(11;17) (q23;q21) [5]</td><td>PLZF (promyelocytic leukaemia zinc finger protein)</td><td>Resistant</td></tr><tr><td>t(5;17) (q35;q21) [6]</td><td>NPM (nucleophosmin)</td><td>Sensitive</td></tr><tr><td>t(11;17) (q13;q21) [... | <table><tr><td>Translocation</td><td>Translocation partner</td><td>ATRA response</td></tr><tr><td>t(11;17) (q23;q21) [5]</td><td>PLZF (promyelocytic leukaemia zinc finger protein)</td><td>Resistant</td></tr></table> | <table><tr><td>Translocation</td><td>Translocation partner</td><td>ATRA response</td></tr><tr><td>t(5;17) (q35;q21) [6]</td><td>NPM (nucleophosmin)</td><td>Sensitive</td></tr><tr><td>t(11;17) (q13;q21) [7]</td><td>NUMA (nuclear mitotic apparatus)</td><td>Sensitive</td></tr><tr><td>der(17) [8]</td><td>STAT5b (signal tra... |
b45c1faf904228b5f1ed982f2eaed6f61865e4c346d75366154e1947276c5c3b.png | simple | <table><tr><td>N = 1094</td><td>Total</td><td>Males (n = 506)</td><td>Females (n = 588)</td><td>χ<sup>2</sup></td></tr><tr><td>Age, mean (SD)</td><td>53.1(11.4)</td><td>53.8(11.6)</td><td>52.5(11.1)</td><td></td></tr><tr><td>Marital status (% married /living together)</td><td>54.6</td><td>61.1</td><td>49.0</td><td... | <table><tr><td>N = 1094</td><td>Total</td><td>Males (n = 506)</td><td>Females (n = 588)</td><td>χ2</td></tr></table> | <table><tr><td>Age, mean (SD)</td><td>53.1(11.4)</td><td>53.8(11.6)</td><td>52.5(11.1)</td><td></td></tr><tr><td>Marital status (% married /living together)</td><td>54.6</td><td>61.1</td><td>49.0</td><td>p < 0.05</td></tr><tr><td>Level of education (%)</td><td></td><td></td><td></td><td></td></tr><tr><td>High</td><td>4... |
824ce2445897b04865caef8d4d0d66df939d5a86b1828bdc714cde6072f933f8.png | simple | <table><tr><td>1. Was an 'a priori' design provided?The research question and inclusion criteria should be established before the conduct of the review.</td><td>□ Yes□ No□ Can't answer□ Not applicable</td></tr><tr><td>2. Was there duplicate study selection and data extraction?There should be at ... | <table><tr><td>1. Was an 'a priori' design provided?The research question and inclusion criteria should be established before the conduct of the review.</td><td>□ Yes□ No□ Can't answer□ Not applicable</td></tr><tr><td>2. Was there duplicate study selection and data extraction?There should be at least two independent da... | <table><tr><td>1. Was an 'a priori' design provided?The research question and inclusion criteria should be established before the conduct of the review.</td><td>□ Yes□ No□ Can't answer□ Not applicable</td></tr><tr><td>3. Was a comprehensive literature search performed?At least two electronic sources should be searched.... |
9228996ee9988f0e57a17b6bd6e775b60bb6c59bc8fe77ded1d7342a96ca1c43.png | simple | <table><tr><td>Nutrient</td><td>Amount (DM)</td></tr><tr><td>Crude protein</td><td>76.9%</td></tr><tr><td>Crude fat</td><td>1.9%</td></tr><tr><td>Ca</td><td>12.31%</td></tr><tr><td>P</td><td>1.03%</td></tr><tr><td>Na</td><td>4.09%</td></tr><tr><td>K</td><td>0.3%</td></tr><tr><td>Mg</td><td>2.08%</td></tr><tr><td>S</td>... | <table><tr><td>Nutrient</td></tr><tr><td>Crude protein</td></tr><tr><td>Crude fat</td></tr><tr><td>Ca</td></tr><tr><td>P</td></tr><tr><td>Na</td></tr><tr><td>K</td></tr><tr><td>Mg</td></tr><tr><td>S</td></tr><tr><td>Mn</td></tr><tr><td>Zn</td></tr><tr><td>Cu</td></tr><tr><td>Co</td></tr><tr><td>I</td></tr><tr><td>Se</t... | <table><tr><td>Amount (DM)</td></tr><tr><td>76.9%</td></tr><tr><td>1.9%</td></tr><tr><td>12.31%</td></tr><tr><td>1.03%</td></tr><tr><td>4.09%</td></tr><tr><td>0.3%</td></tr><tr><td>2.08%</td></tr><tr><td>0.24%</td></tr><tr><td>615 ppm</td></tr><tr><td>924 ppm</td></tr><tr><td>308 ppm</td></tr><tr><td>26 ppm</td></tr><t... |
8bae349887d3020bde49b47bb98d37d5864128511bef791cda4d05c48859cf75.png | simple | <table><tr><td>#</td><td>m/z</td><td>z</td><td>m</td><td>Sequence proposal</td><td>Alignment</td><td>Protein homologue</td></tr><tr><td>1</td><td>1185.6</td><td>3</td><td>3553.8</td><td>SNVLYGPDTPTLSQSLGNS</td><td>Query: NVLYGPDTPTLSQS</td><td>CEACAM8</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td>NVLYGP... | <table><tr><td>#</td><td>m/z</td><td>z</td><td>m</td><td>Sequence proposal</td><td>Alignment</td><td>Protein homologue</td></tr></table> | <table><tr><td>1</td><td>1185.6</td><td>3</td><td>3553.8</td><td>SNVLYGPDTPTLSQSLGNS</td><td>Query: NVLYGPDTPTLSQS</td><td>CEACAM8</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td>NVLYGPD PT+S S</td><td>P31997</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td>Sbjct: NVLYGPDAPTISPS</td><td>H. sa... |
fef84bac2c52dbafadeb88e27d7220609590a0b4ed53ffb62f5e10ef5fc1c430.png | simple | <table><tr><td></td><td>Nutritional factors</td><td>Chick -starter diet</td><td>Chick-Grower diet</td></tr><tr><td>1.</td><td>ME<sup>*</sup> Kcal/ kg</td><td>2915</td><td>2915</td></tr><tr><td>2.</td><td>Crude protein %</td><td>17.50</td><td>15.00</td></tr><tr><td>3.</td><td>Fat %</td><td>3-4</td><td>3-4</td></tr><tr><... | <table><tr><td></td><td>Nutritional factors</td><td>Chick -starter diet</td></tr><tr><td>1.</td><td>ME* Kcal/ kg</td><td>2915</td></tr><tr><td>2.</td><td>Crude protein %</td><td>17.50</td></tr><tr><td>3.</td><td>Fat %</td><td>3-4</td></tr><tr><td>4.</td><td>Fibre %</td><td>3-4</td></tr><tr><td>5.</td><td>Lysine %</td><... | <table><tr><td>Chick-Grower diet</td></tr><tr><td>2915</td></tr><tr><td>15.00</td></tr><tr><td>3-4</td></tr><tr><td>3-4</td></tr><tr><td>0.75</td></tr><tr><td>0.35</td></tr><tr><td>1.00</td></tr><tr><td>0.60</td></tr><tr><td>4450</td></tr><tr><td>1600</td></tr><tr><td>15.0</td></tr><tr><td>1.00</td></tr><tr><td>45.0</t... |
a62ebbbf80a86ae56a12c0c742a2443163e760262a6e0a2dc3a88514da62e418.png | complex | <table><tr><td rowspan="2"></td><td colspan="4">Pharmacist</td><td colspan="4">PMV</td></tr><tr><td colspan="2">Any FP training</td><td colspan="2">No FP training</td><td colspan="2">Any FP training</td><td colspan="2">No FP training</td></tr><tr><td>Minimum age</td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td... | <table><tr><td rowspan="2"></td><td colspan="4">Pharmacist</td><td colspan="4">PMV</td></tr><tr><td colspan="2">Any FP training</td><td colspan="2">No FP training</td><td colspan="2">Any FP training</td><td colspan="2">No FP training</td></tr><tr><td>Minimum age</td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td... | <table><tr><td rowspan="2"></td><td colspan="4">Pharmacist</td><td colspan="4">PMV</td></tr><tr><td colspan="2">Any FP training</td><td colspan="2">No FP training</td><td colspan="2">Any FP training</td><td colspan="2">No FP training</td></tr><tr><td>Male condom</td><td>172</td><td>0.9</td><td>238</td><td>0.9</td><td>2... |
6cef1e235238f86f47185f304670af9a0f69e592154ad90a74551a6baaa17afb.png | simple | <table><tr><td>Genotypes/alleles</td><td>Patients (47)</td><td>Controls (76)</td></tr><tr><td>ID</td><td>26 (55.3%)</td><td>34 (44.7%)</td></tr><tr><td>DD</td><td>14 (29.8%)</td><td>30 (39.5%)</td></tr><tr><td>II</td><td>7 (14.9%)</td><td>12 (15.8%)</td></tr><tr><td>AC</td><td>20 (42.6%)</td><td>31 (40.8%)</td></tr><tr... | <table><tr><td>Genotypes/alleles</td><td>Patients (47)</td><td>Controls (76)</td></tr><tr><td>ID</td><td>26 (55.3%)</td><td>34 (44.7%)</td></tr><tr><td>DD</td><td>14 (29.8%)</td><td>30 (39.5%)</td></tr><tr><td>II</td><td>7 (14.9%)</td><td>12 (15.8%)</td></tr><tr><td>AC</td><td>20 (42.6%)</td><td>31 (40.8%)</td></tr><tr... | <table><tr><td>MM</td><td>%)</td><td> (31.6%)</td></tr><tr><td>TT</td><td>7 (14.9%)</td><td>12 (15.8%)</td></tr><tr><td>D allele presence</td><td>40 (85.1%)</td><td>64 (84.2%)</td></tr><tr><td>I allele presence</td><td>33 (70.2%)</td><td>46 (60.5%)</td></tr><tr><td>A allele presence</td><td>45 (95.7%)</td><td>71 (93.4%... |
d232dd30e0c0055c935df65b0abf19b2826965777005aacd7f17d2dffd67b4b7.png | simple | <table><tr><td>Assumptions</td><td>Justification</td></tr><tr><td>66.45% of standard care monitoring occurs in primary care with practice nurses</td><td>Based on previous TAR (manufacturers submission for TA256)70</td></tr><tr><td>60% of the cohort have atrial fibrillation, 40% have an artificial heart valve</td><td>In... | <table><tr><td>Assumptions</td></tr><tr><td>66.45% of standard care monitoring occurs in primary care with practice nurses</td></tr><tr><td>60% of the cohort have atrial fibrillation, 40% have an artificial heart valve</td></tr><tr><td>Average age of the cohort is 65 years, and 55% are male</td></tr><tr><td>50% of self... | <table><tr><td>Justification</td></tr><tr><td>Based on previous TAR (manufacturers submission for TA256)70</td></tr><tr><td>In line with the observed proportions of patients with these conditions in self-monitoring trials68</td></tr><tr><td>In line with the observed mean age of included patients with these conditions i... |
7a50a78e5e4b92568f44aafd16772f792890b3cb0c95b33a502ceabe8fb2fa87.png | simple | <table><tr><td></td><td>HR (95% CI)</td><td>P</td></tr><tr><td>ABDC treatment</td><td>3.63 (1.57-8.34)</td><td>0.003</td></tr><tr><td><i>Candida</i> spp. load until day 5</td><td>1.19 (0.70-2.02)</td><td>0.51</td></tr><tr><td><i>Candida</i> spp. load after day 5</td><td>0.67 (0.31-1.47)</td><td>0.32</td></tr><tr><td>Du... | <table><tr><td></td><td>HR (95% CI)</td><td>P</td></tr><tr><td>ABDC treatment</td><td>3.63 (1.57-8.34)</td><td>0.003</td></tr><tr><td>Candida spp. load until day 5</td><td>1.19 (0.70-2.02)</td><td>0.51</td></tr><tr><td>Candida spp. load after day 5</td><td>0.67 (0.31-1.47)</td><td>0.32</td></tr><tr><td>Duration of colo... | <table><tr><td></td><td>HR (95% CI)</td><td>P</td></tr><tr><td>CPIS day 7</td><td>0.91 (0.76-1.10)</td><td>0.32</td></tr><tr><td>LIS day 7</td><td>0.60 (0.40-0.91)</td><td>0.02</td></tr></table> |
e1a84eeca240c0e03c38572b1bae87a73b423515aef0b807304b77cf457ecc14.png | complex | <table><tr><td>Clinical Features</td><td colspan="2">Colombia</td><td colspan="2">Mexico</td><td colspan="2">Latinos USA (NLAAS)</td><td colspan="2">USA(NCS-R)</td></tr><tr><td></td><td>n<sup>¥</sup></td><td>%(95%CI)*</td><td>n<sup>¥</sup></td><td>%(95%CI)*</td><td>n<sup>¥</sup></td><td>%(95%CI)*</td><td... | <table><tr><td>Clinical Features</td><td colspan="2">Colombia</td><td colspan="2">Mexico</td><td colspan="2">Latinos USA (NLAAS)</td><td colspan="2">USA(NCS-R)</td></tr><tr><td></td><td>n¥</td><td>%(95%CI)*</td><td>n¥</td><td>%(95%CI)*</td><td>n¥</td><td>%(95%CI)*</td><td>n¥</td><td>%(95%CI)*</td></tr><tr><td>Recurrent... | <table><tr><td>Clinical Features</td><td colspan="2">Colombia</td><td colspan="2">Mexico</td><td colspan="2">Latinos USA (NLAAS)</td><td colspan="2">USA(NCS-R)</td></tr><tr><td></td><td>n¥</td><td>%(95%CI)*</td><td>n¥</td><td>%(95%CI)*</td><td>n¥</td><td>%(95%CI)*</td><td>n¥</td><td>%(95%CI)*</td></tr><tr><td>cial prob... |
f13af735eda9f71f2bc73698d080922a8446fb56d8efea35dd4c6ffd56d057a5.png | complex | <table><tr><td rowspan="2">Persistent Organic Pollutants</td><td colspan="3">∆ cMetS Score</td><td colspan="3">Relative Change of Glucose (%)</td><td colspan="3">Relative Change of HDL−c (%)</td><td colspan="3">Relative Change of TG (%)</td><td colspan="3">Relative Change of SBP (%)</td><td colspan="3">Rela... | <table><tr><td>Persistent Organic Pollutants</td><td colspan="3">∆ cMetS Score</td><td colspan="3">Relative Change of Glucose (%)</td><td colspan="3">Relative Change of HDL−c (%)</td><td colspan="3">Relative Change of TG (%)</td><td colspan="3">Relative Change of SBP (%)</td><td colspan="3">Relative Change of DBP (%)</... | <table><tr><td>Persistent Organic Pollutants</td><td>β</td><td colspan="2">95% CI</td><td>β</td><td colspan="2">95% CI</td><td>β</td><td colspan="2">95% CI</td><td>β</td><td colspan="2">95% CI</td><td>β</td><td colspan="2">95% CI</td><td>β</td><td colspan="2">95% CI</td></tr><tr><td>PCB 52</td><td>0.64 a</td><td>0.21</... |
874c9fdccc9f38e476d230b0990c9748938b15b2b1c356fa0bff1651b90bd43b.png | simple | <table><tr><td></td><td>ECW</td><td>ECS</td><td>ECT</td><td>NW</td></tr><tr><td>ECW</td><td>1</td><td></td><td></td><td>0.33</td></tr><tr><td>ECS</td><td>1</td><td>1</td><td></td><td>0.33</td></tr><tr><td>ECT</td><td>1</td><td>1</td><td>1</td><td>0.33</td></tr></table> | <table><tr><td></td><td>ECW</td></tr><tr><td>ECW</td><td>1</td></tr><tr><td>ECS</td><td>1</td></tr><tr><td>ECT</td><td>1</td></tr></table> | <table><tr><td>ECS</td><td>ECT</td><td>NW</td></tr><tr><td></td><td></td><td>0.33</td></tr><tr><td>1</td><td></td><td>0.33</td></tr><tr><td>1</td><td>1</td><td>0.33</td></tr></table> |
ccaca0382305d1ea31554e96a0466f89a472886d7e5dcdc05c1af29712c1d661.png | complex | <table><tr><td rowspan="2">Crude plant extracts</td><td colspan="3">LC<sub>50</sub></td></tr><tr><td>6 hrs</td><td>12 hrs</td><td>24 hrs</td></tr><tr><td>HE I</td><td>—</td><td>3943</td><td>3880</td></tr><tr><td>CE I</td><td>2836</td><td>183</td><td>2</td></tr><tr><td>ME I</td><td>2840</td><td>183</td><td>16</td>... | <table><tr><td rowspan="2">Crude plant extracts</td></tr><tr></tr><tr><td>HE I</td></tr><tr><td>CE I</td></tr><tr><td>ME I</td></tr><tr><td>CE II</td></tr><tr><td>BE II</td></tr></table> | <table><tr><td colspan="3">LC50</td></tr><tr><td>6 hrs</td><td>12 hrs</td><td>24 hrs</td></tr><tr><td>—</td><td>3943</td><td>3880</td></tr><tr><td>2836</td><td>183</td><td>2</td></tr><tr><td>2840</td><td>183</td><td>16</td></tr><tr><td>2836</td><td>542</td><td>79</td></tr><tr><td>2840</td><td>545</td><td>194</td></tr><... |
ad3ba86dd73fb166a26bba30129dac18f0fff0944e19edc8765fe8a7ebeba9a9.png | simple | <table><tr><td>groups</td><td>Rhizoma Coptidis</td><td>Radix Scutellariae</td><td>Cortex Phellodendri</td><td>Fructus Gardeniae</td></tr><tr><td>F1</td><td>3</td><td>2</td><td>2</td><td>3</td></tr><tr><td>F2</td><td>6</td><td>2</td><td>2</td><td>3</td></tr><tr><td>F3</td><td>3</td><td>4</td><td>4</td><td>6</td></tr><tr... | <table><tr><td>groups</td><td>Rhizoma Coptidis</td><td>Radix Scutellariae</td><td>Cortex Phellodendri</td><td>Fructus Gardeniae</td></tr><tr><td>F1</td><td>3</td><td>2</td><td>2</td><td>3</td></tr><tr><td>F2</td><td>6</td><td>2</td><td>2</td><td>3</td></tr></table> | <table><tr><td>F3</td><td>3</td><td>4</td><td>4</td><td>6</td></tr><tr><td>F4</td><td>3</td><td>4</td><td>2</td><td>12</td></tr><tr><td>F5</td><td>3</td><td>2</td><td>8</td><td>6</td></tr><tr><td>F6</td><td>3</td><td>8</td><td>4</td><td>3</td></tr><tr><td>F7</td><td>12</td><td>4</td><td>8</td><td>3</td></tr><tr><td>F8<... |
03db7a532f64a38cde3be448fb75ad85c9089c83301787ba901f0d4b08e2bd1b.png | complex | <table><tr><td>Reagent</td><td>AS</td><td>DRG</td><td>LB</td><td>KOH</td><td>NP/PEG</td><td> </td></tr><tr><td>Metabolites</td><td>Terpenes and steroids</td><td>Alkaloids</td><td>Triterpenes and steroids</td><td>Coumarins and anthraquinones</td><td>Flavonoids andphenolic acids</td><td>Saponins</td></tr><tr><td colspan=... | <table><tr><td>Reagent</td><td>AS</td><td>DRG</td><td>LB</td></tr><tr><td>Metabolites</td><td>Terpenes and steroids</td><td>Alkaloids</td><td>Triterpenes and steroids</td></tr><tr><td colspan="4">L. origanoides leaves</td></tr><tr><td>HEFL</td><td>++</td><td>−</td><td>+</td></tr><tr><td>DIFL</td><td>+</td><td>−</td><td... | <table><tr><td>KOH</td><td>NP/PEG</td><td></td></tr><tr><td>Coumarins and anthraquinones</td><td>Flavonoids andphenolic acids</td><td>Saponins</td></tr><tr><td colspan="3">L. origanoides leaves</td></tr><tr><td>+</td><td>+</td><td>−</td></tr><tr><td>+</td><td>+</td><td>−</td></tr><tr><td>−</td><td>++</td><td>+</td></tr... |
1b3efcb2847f18f0d6083c0dfcc527edfe3e9ed91515fe534a3764057efbbcdb.png | simple | <table><tr><td>Variable</td><td>Patients with vascular events (<i>n</i> = 7)</td><td>Patients without vascular events(<i>n</i> = 83)</td></tr><tr><td>Age (years), median (IQR) </td><td>47 (31–62)</td><td>50 (40–62)</td></tr><tr><td>Males, <i>n</i> (%)</td><td>4 (57.1%)</td><td>43 (51.8%)</td></tr><tr><td>Pe... | <table><tr><td>Variable</td><td>Patients with vascular events (n = 7)</td><td>Patients without vascular events(n = 83)</td></tr><tr><td>Age (years), median (IQR)</td><td>47 (31–62)</td><td>50 (40–62)</td></tr><tr><td>Males, n (%)</td><td>4 (57.1%)</td><td>43 (51.8%)</td></tr><tr><td>Personal history VTE, n (%)</td><td>... | <table><tr><td>JAK2 V617F mutation, n (%)**</td><td>1 (20.0%)</td><td>2 (5.4%)</td></tr><tr><td>Factor V Leiden or prothrombin G20210A mutation, n (%)**</td><td>1 (20.0%)</td><td>8 (16.0%)</td></tr><tr><td>Previous VKA treatment duration (months), median (IQR)</td><td>9.9 (3.2–12.9)</td><td>12.7 (7.2–24.0)</td></tr><tr... |
e63ca7f5e25f1c0de5e2618ef9d2ea015ec57cf6d2ad9f2a90d4836b117deb57.png | simple | <table><tr><td>Tests</td><td>Patient’s data</td><td>Units</td><td>Reference ranges</td></tr><tr><td>Cortisol dynamic</td><td>1 (confirmed twice)</td><td>nmol/L</td><td> </td></tr><tr><td>ACTH</td><td>46.2</td><td>pg/mL</td><td><46.0</td></tr><tr><td>Na<sup>+</sup></td><td>134</td><td>mmol/L</td><td>136 to 145<... | <table><tr><td>Tests</td><td>Patient’s data</td><td>Units</td><td>Reference ranges</td></tr><tr><td>Cortisol dynamic</td><td>1 (confirmed twice)</td><td>nmol/L</td><td></td></tr><tr><td>ACTH</td><td>46.2</td><td>pg/mL</td><td><46.0</td></tr><tr><td>Na+</td><td>134</td><td>mmol/L</td><td>136 to 145</td></tr><tr><td>K+</... | <table><tr><td>antibodies</td><td>ive</td><td></td><td>10</td></tr><tr><td>Blood culture</td><td>Negative</td><td></td><td></td></tr><tr><td>Urine culture</td><td>Negative</td><td></td><td></td></tr><tr><td>Stool culture</td><td>Negative</td><td></td><td></td></tr></table> |
b59396da109b84414cdc11b2617a875e1d5103d3520f4ebd50ea2e6997b61fab.png | complex | <table><tr><td>Variable</td><td>Company</td><td colspan="2">Prestudy period(<i>n </i>= 166/133)<sup>c</sup></td><td colspan="2">Study period(<i>n </i>= 174/144)<sup>c</sup></td><td>Age-adjusted HR(95% CI)</td><td>HR adjusted model<sup>d</sup>(95% CI)</td></tr><tr><td></td><td></td><td>Number</td><td>Incidence</td><td>N... | <table><tr><td>Variable</td><td>Company</td><td colspan="2">Prestudy period(n = 166/133)c</td><td colspan="2">Study period(n = 174/144)c</td><td>Age-adjusted HR(95% CI)</td><td>HR adjusted modeld(95% CI)</td></tr><tr><td></td><td></td><td>Number</td><td>Incidence</td><td>Number</td><td>Incidence</td><td></td><td></td><... | <table><tr><td>Variable</td><td>Company</td><td colspan="2">Prestudy period(n = 166/133)c</td><td colspan="2">Study period(n = 174/144)c</td><td>Age-adjusted HR(95% CI)</td><td>HR adjusted modeld(95% CI)</td></tr><tr><td></td><td></td><td>Number</td><td>Incidence</td><td>Number</td><td>Incidence</td><td></td><td></td><... |
43f38cde6f7b099ae382887d03ec6189df7f07a19f4f882c384771f97862a0a3.png | simple | <table><tr><td>Food item</td><td>Adjusted OR* (95 % CI)</td><td><i>P</i> value</td></tr><tr><td>Cold appetizer—pork liver</td><td>3.23 (1.26–8.30)</td><td>0.01</td></tr><tr><td>Lamb chops, carrots, radish wrapped in lotus leaves</td><td>3.98 (1.74–9.11)</td><td>0.001</td></tr></table> | <table><tr><td>Food item</td><td>Adjusted OR* (95 % CI)</td><td>P value</td></tr></table> | <table><tr><td>Cold appetizer—pork liver</td><td>3.23 (1.26–8.30)</td><td>0.01</td></tr><tr><td>Lamb chops, carrots, radish wrapped in lotus leaves</td><td>3.98 (1.74–9.11)</td><td>0.001</td></tr></table> |
b85507071d7a15968fdee2830051383ea20db16a067a0586c5e17257864027c7.png | simple | <table><tr><td>Diet</td><td>Echolocation Call Type</td><td>Bat Species</td></tr><tr><td>Fruits</td><td>Broadband clicks of short duration</td><td>Egyptian fruit bat</td></tr><tr><td>Moths, beetles, flies and other insects</td><td>Narrowband with dominant fundamental harmonic</td><td>Eastern red bat</td></tr><tr><td>Fly... | <table><tr><td>Diet</td><td>Echolocation Call Type</td><td>Bat Species</td></tr><tr><td>Fr</td><td>Broadband </td><td>Egyptian fruit </td></tr></table> | <table><tr><td>uits</td><td>clicks of short duration</td><td>bat</td></tr><tr><td>Moths, beetles, flies and other insects</td><td>Narrowband with dominant fundamental harmonic</td><td>Eastern red bat</td></tr><tr><td>Flying insects and small fruits</td><td>Multiharmonic narrowband, faintly audible to humans</td><td>Bla... |
a476dbcd2fe3bf5da04ce8b93d6e1329b22278c986965d2d4e60612637712907.png | simple | <table><tr><td></td><td>Control</td><td>Mild</td><td>Moderate to severe</td></tr><tr><td></td><td> (<i>n</i> = 6)</td><td> (<i>n</i> = 10)</td><td>(<i>n</i> = 10) </td></tr><tr><td>PMN (%)</td><td>10.6 ± 1.7</td><td>3.8 ± 1.7</td><td>18.6 ± 11.3</td></tr><tr><td>Lymph (%)</td><td>2.5 ± 0.5</td><td>2... | <table><tr><td></td><td>Control</td><td>Mild</td><td>Moderate to severe</td></tr><tr><td></td><td>(n = 6</td><td>(n = </td><td>(n = 10</td></tr></table> | <table><tr><td></td><td>)</td><td>10)</td><td>)</td></tr><tr><td>PMN (%)</td><td>10.6 ± 1.7</td><td>3.8 ± 1.7</td><td>18.6 ± 11.3</td></tr><tr><td>Lymph (%)</td><td>2.5 ± 0.5</td><td>2.3 ± 0.8</td><td>3.4 ± 1.5</td></tr><tr><td>Macrophage (%)</td><td>85 ± 21</td><td>93.8 ± 2.3</td><td>68 ± 21</td></tr></table> |
4c900a040042bca3d61a6eb615d4dafb2e0152feae1021ad1d696bd2c32b13ed.png | complex | <table><tr><td rowspan="2">Variables</td><td>Univariate</td><td colspan="3">Multivariate</td></tr><tr><td><i>P</i> value</td><td><i>P</i> value</td><td colspan="2">OR (95% CI)</td></tr><tr><td colspan="5">Control group</td></tr><tr><td> Age, y</td><td>0.041</td><td>0.125</td><td></td><td></td></tr><tr><td> Female sex</... | <table><tr><td rowspan="2">Variables</td><td>Univariate</td><td colspan="3">Multivariate</td></tr><tr><td>P value</td><td>P value</td><td colspan="2">OR (95% CI)</td></tr><tr><td colspan="5">Control group</td></tr><tr><td>Age, y</td><td>0.041</td><td>0.125</td><td></td><td></td></tr><tr><td>Female sex</td><td>0.463</td... | <table><tr><td rowspan="2">Variables</td><td>Univariate</td><td colspan="3">Multivariate</td></tr><tr><td>P value</td><td>P value</td><td colspan="2">OR (95% CI)</td></tr><tr><td>NYHA class</td><td>0.094</td><td>0.130</td><td></td><td></td></tr><tr><td>Diabetes</td><td>0.127</td><td>0.394</td><td></td><td></td></tr><tr... |
d1920694b47348191a7946fca8f461723a238aa980a6e7b7f37fc7a620ccadb7.png | simple | <table><tr><td>No.</td><td>Name</td><td>Country</td><td>Year</td><td>Accession Number</td></tr><tr><td>1</td><td>CH-1a</td><td>China</td><td>1996</td><td>AY032626</td></tr><tr><td>2</td><td>BJ-4</td><td>China</td><td>2000</td><td>AF331831</td></tr><tr><td>3</td><td>HB-1(sh)/2002</td><td>China</td><td>2002</td><td>AY150... | <table><tr><td>No.</td><td>Name</td><td>Country</td><td>Year</td><td>Accession Number</td></tr><tr><td>1</td><td>CH-1a</td><td>China</td><td>1996</td><td>AY032626</td></tr><tr><td>2</td><td>BJ-4</td><td>China</td><td>2000</td><td>AF331831</td></tr><tr><td>3</td><td>HB-1(sh)/2002</td><td>China</td><td>2002</td><td>AY150... | <table><tr><td>No.</td><td>Name</td><td>Country</td><td>Year</td><td>Accession Number</td></tr><tr><td>8</td><td>CH-1R</td><td>China</td><td>2008</td><td>EU807840</td></tr><tr><td>9</td><td>HB-1</td><td>China</td><td>2008</td><td>EU360130</td></tr><tr><td>10</td><td>WUH4</td><td>China</td><td>2011</td><td>JQ326271</td>... |
80c1d10f7bff34c91d5a13cfc2fc1ae3917cdbb9b2290e9da43e52c6e6224429.png | simple | <table><tr><td>No</td><td>SSR</td><td>Africa</td><td>Asia</td><td>Central America</td><td>South America</td></tr><tr><td>1</td><td>Jc01 A</td><td>0.09</td><td>0.02</td><td>0.39</td><td>0.15</td></tr><tr><td>2</td><td>Jc01 B</td><td>0.10</td><td>0.00</td><td>0.19</td><td>0.15</td></tr><tr><td>3</td><td>Jc01 C</td><td>0.... | <table><tr><td>No</td><td>SSR</td><td>Africa</td><td>Asia</td><td>Central America</td><td>South America</td></tr><tr><td>1</td><td>Jc01 A</td><td>0.09</td><td>0.02</td><td>0.39</td><td>0.15</td></tr><tr><td>2</td><td>Jc01 B</td><td>0.10</td><td>0.00</td><td>0.19</td><td>0.15</td></tr><tr><td>3</td><td>Jc01 C</td><td>0.... | <table><tr><td>No</td><td>SSR</td><td>Africa</td><td>Asia</td><td>Central America</td><td>South America</td></tr><tr><td>9</td><td>Jc10 A</td><td>0.00</td><td>0.00</td><td>0.06</td><td>0.00</td></tr><tr><td>10</td><td>Jc10 B</td><td>0.00</td><td>0.00</td><td>0.35</td><td>0.00</td></tr><tr><td>11</td><td>Jc13 A</td><td>... |
42573da45aebd25d467962b73a5371ed60fb6d960540d3240ee2e6e79a7e8193.png | simple | <table><tr><td></td><td>Sensitivity (95% CI)</td><td>Specificity (95% CI)</td><td>Positive predictive value (95% CI)</td><td>Negative predictive value (95% CI)</td></tr><tr><td>GBS>0</td><td>100 (87.7–100)</td><td>0 (0–2.9)</td><td>18.3 (12.5–25.4)</td><td>-</td></tr><tr><td>PRS >0</td><td>100 (... | <table><tr><td></td><td>Sensitivity (95% CI)</td><td>Specificity (95% CI)</td><td>Positive predictive value (95% CI)</td><td>Negative predictive value (95% CI)</td></tr><tr><td>G</td><td>1</td><td>0 (</td><td>18.3 </td><td>-</td></tr></table> | <table><tr><td></td><td>Sensitivity (95% CI)</td><td>Specificity (95% CI)</td><td>Positive predictive value (95% CI)</td><td>Negative predictive value (95% CI)</td></tr><tr><td>BS>0</td><td>00 (87.7–100)</td><td>0–2.9)</td><td>(12.5–25.4)</td><td></td></tr><tr><td>PRS >0</td><td>100 (87.7–100)</td><td>12 (6.9–19)</td><... |
43c6dcc0f7c6c2f91bfa850c1de87927620a7028cb4f63898d511a08e2caafef.png | simple | <table><tr><td>Dataset</td><td>DB size</td><td>Prior</td><td>Posterior</td><td>MetAssign</td><td>mzMatch</td><td>CAMERA</td></tr><tr><td>std1.NEG</td><td>100</td><td>0.93</td><td>0.93</td><td>0.90</td><td>0.68</td><td>0.17</td></tr><tr><td></td><td>600</td><td>0.71</td><td>0.74</td><td>0.81</td><td>0.56</td><td>0.16</t... | <table><tr><td>Dataset</td><td>DB size</td><td>Prior</td><td>Posterior</td><td>MetAssign</td><td>mzMatch</td><td>CAMERA</td></tr><tr><td>std1.NEG</td><td>100</td><td>0.93</td><td>0.93</td><td>0.90</td><td>0.68</td><td>0.17</td></tr><tr><td></td><td>600</td><td>0.71</td><td>0.74</td><td>0.81</td><td>0.56</td><td>0.16</t... | <table><tr><td>Dataset</td><td>DB size</td><td>Prior</td><td>Posterior</td><td>MetAssign</td><td>mzMatch</td><td>CAMERA</td></tr><tr><td>std3.NEG</td><td>100</td><td>0.66</td><td>0.67</td><td>0.69</td><td>0.39</td><td>0.15</td></tr><tr><td></td><td>600</td><td>0.29</td><td>0.35</td><td>0.40</td><td>0.21</td><td>0.13</t... |
6f8fe3d11f88e74aeac87ccea29a8f48ee4db7b2d7b9e5ece5fedf80dfc95e34.png | simple | <table><tr><td>Parameter</td><td>MEAN</td><td>STD</td><td>MIN</td><td>MAX</td></tr><tr><td>ACCX [g]</td><td>0.09</td><td>0.20</td><td>−0.95</td><td>0.59</td></tr><tr><td>ACCY [g]</td><td>0.88</td><td>0.17</td><td>0.27</td><td>1.99</td></tr><tr><td>ACCZ [g]</td><td>0.11</td><td>0.43</td><td>−1.13</td><td>1.0... | <table><tr><td>Parameter</td><td>MEAN</td><td>STD</td><td>MIN</td><td>MAX</td></tr><tr><td>ACCX [g]</td><td>0.09</td><td>0.20</td><td>−0.95</td><td>0.59</td></tr></table> | <table><tr><td>ACCY [g]</td><td>0.88</td><td>0.17</td><td>0.27</td><td>1.99</td></tr><tr><td>ACCZ [g]</td><td>0.11</td><td>0.43</td><td>−1.13</td><td>1.02</td></tr></table> |
1ede15a6416caa9604aad64ca45fd0e4f1599999ecaae3fae157f5d8be195be0.png | complex | <table><tr><td>Characteristic</td><td>Control (<i>n</i> = 62)</td><td>Template-developed (<i>n</i> = 68)</td><td>Bespoke user-tested (<i>n</i> = 63)</td><td>Total (<i>n</i> = 193)</td></tr><tr><td colspan="5">Gender, <i>n</i> (%)</td></tr><tr><td> Male</td><td>24 (38.7)</td><td>32 (47.8)</td><td>27 (43.6)</td><td>83 (4... | <table><tr><td>Characteristic</td><td>Control (n = 62)</td><td>Template-developed (n = 68)</td><td>Bespoke user-tested (n = 63)</td><td>Total (n = 193)</td></tr><tr><td colspan="5">Gender, n (%)</td></tr></table> | <table><tr><td>Male</td><td>24 (38.7)</td><td>32 (47.8)</td><td>27 (43.6)</td><td>83 (43.5)</td></tr><tr><td colspan="5">Age</td></tr><tr><td>Mean (SD)</td><td>78.3 (5.8)</td><td>78.6 (6.6)</td><td>77.5 (7.8)</td><td>78.1 (6.8)</td></tr><tr><td colspan="5">Fallen in previous 6 months? n (%)</td></tr><tr><td>Yes</td><td... |
37b20271374a5ff3eb9195ffecf3a61f295c316e58feba8eabf1745a3518e9a3.png | simple | <table><tr><td> </td><td>Non-vertex n/N, (%) N = 369</td><td>Vertex n/N, (%) 1,055</td><td>Crude odds ratio (95% CI)</td><td>Adjusted odds ratio<sup>a </sup>(95% CI)</td></tr><tr><td>Maternal death</td><td>0/369 (0.0)</td><td>1/1055 (0.1)</td><td>*</td><td>*</td></tr><tr><td>ICU admission</td><td>17/369 (4.6)</td><td>1... | <table><tr><td></td><td>Non-vertex n/N, (%) N = 369</td><td>Vertex n/N, (%) 1,055</td><td>Crude odds ratio (95% CI)</td><td>Adjusted odds ratioa (95% CI)</td></tr><tr><td>Maternal death</td><td>0/369 (0.0)</td><td>1/1055 (0.1)</td><td>*</td><td>*</td></tr><tr><td>ICU admission</td><td>17/369 (4.6)</td><td>18/1055 (1.7)... | <table><tr><td> perineal laceration</td><td>/369 (1.4)</td><td>– 1.91)</td><td>*</td></tr></table> |
c4a353a7a5c0642afb9e6f1cb1a581c9583e0f43072e908e09293a1e7a9cbd47.png | complex | <table><tr><td rowspan="3">Gene Expression</td><td colspan="2">Normal-Weight Control (<i>n</i> = 10)</td><td colspan="2">Morbidly Obese (<i>n</i> = 30)</td></tr><tr><td>VAT</td><td>SAT</td><td>VAT</td><td>SAT</td></tr><tr><td>Mean ± SD</td><td>Mean ± SD</td><td>Mean ± SD</td><td>Mean ± SD</td></tr><... | <table><tr><td rowspan="3">Gene Expression</td><td colspan="2">Normal-Weight Control (n = 10)</td><td colspan="2">Morbidly Obese (n = 30)</td></tr><tr><td>VAT</td><td>SAT</td><td>VAT</td><td>SAT</td></tr><tr><td>Mean ± SD</td><td>Mean ± SD</td><td>Mean ± SD</td><td>Mean ± SD</td></tr><tr><td>IL-6</td><td>2.38 ± 1.52</t... | <table><tr><td rowspan="3">Gene Expression</td><td colspan="2">Normal-Weight Control (n = 10)</td><td colspan="2">Morbidly Obese (n = 30)</td></tr><tr><td>VAT</td><td>SAT</td><td>VAT</td><td>SAT</td></tr><tr><td>Mean ± SD</td><td>Mean ± SD</td><td>Mean ± SD</td><td>Mean ± SD</td></tr><tr><td>Resistin</td><td>0.008 ± 0.... |
9ee3eec58a5a2792d5a55945219ca8d095d12f3dff6121147f351ed807a9f08e.png | complex | <table><tr><td rowspan="2">Sample</td><td colspan="3">Chemical Composition (in wt %) </td></tr><tr><td>Ni</td><td>Ti</td><td>Al</td></tr><tr><td>NiTi46</td><td>54.0</td><td>46.0</td><td>-</td></tr><tr><td>NiTiAl1</td><td>53.5</td><td>45.5</td><td>1.0</td></tr><tr><td>NiTiAl3</td><td>52.4</td><td>44.6</td><td>3.0</td></... | <table><tr><td rowspan="2">Sample</td><td colspan="3">Chemical Composition (in wt %)</td></tr><tr><td>Ni</td><td>Ti</td><td>Al</td></tr><tr><td>NiTi46</td><td>54.0</td><td>46.0</td><td>-</td></tr><tr><td>NiTiAl1</td><td>53.5</td><td>45.5</td><td>1.0</td></tr></table> | <table><tr><td>NiTiAl3</td><td>52.4</td><td>44.6</td><td>3.0</td></tr><tr><td>NiTiAl5</td><td>51.3</td><td>43.7</td><td>5.0</td></tr><tr><td>NiTiAl7</td><td>50.2</td><td>42.8</td><td>7.0</td></tr></table> |
29bcd47a4b33f53603a0462cca290e2769cb6e29f05c8f2f85b866be4a983675.png | complex | <table><tr><td>Surgical procedure classification (three-character ICD 10 code)</td><td>Number of hospital discharges</td><td>Number of adverse events (%)</td><td colspan="5">Degree of disability (no. of patients)</td></tr><tr><td></td><td></td><td></td><td>Sick leave ≤ 3 months</td><td>1-15%</td><td>16-30%</td><t... | <table><tr><td>Surgical procedure classification (three-character ICD 10 code)</td><td>Number of hospital discharges</td><td>Number of adverse events (%)</td><td colspan="5">Degree of disability (no. of patients)</td></tr><tr><td></td><td></td><td></td><td>Sick leave ≤ 3 months</td><td>1-15%</td><td>16-30%</td><td>> 30... | <table><tr><td>Surgical procedure classification (three-character ICD 10 code)</td><td>Number of hospital discharges</td><td>Number of adverse events (%)</td><td colspan="5">Degree of disability (no. of patients)</td></tr><tr><td></td><td></td><td></td><td>Sick leave ≤ 3 months</td><td>1-15%</td><td>16-30%</td><td>> 30... |
22b0c46cce177b1f355c9ccbd443ad58073bd725a6ba202e7d1c3425c8f8a0ac.png | simple | <table><tr><td>Variable</td><td>Odds ratio</td><td>Lower 95 % CI</td><td>Upper 95 % CI</td><td>P value</td></tr><tr><td>Body Area (n = 194, m = 18)</td><td></td><td></td><td></td><td></td></tr><tr><td>Girth</td><td>Ref</td><td></td><td></td><td></td></tr><tr><td>Back</td><td>2.56</td><td>1.61</td><td>4.07</td><td><0... | <table><tr><td>Variable</td><td>Odds ratio</td><td>Lower 95 % CI</td><td>Upper 95 % CI</td><td>P value</td></tr><tr><td>Body Area (n = 194, m = 18)</td><td></td><td></td><td></td><td></td></tr><tr><td>Girth</td><td>Ref</td><td></td><td></td><td></td></tr><tr><td>Back</td><td>2.56</td><td>1.61</td><td>4.07</td><td><0.00... | <table><tr><td>Age (n = 133, m = 17)</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>1.03</td><td>1.002</td><td>1.05</td><td>0.034</td></tr><tr><td>Working Hours/Day (n = 194, m = 18)</td><td></td><td></td><td></td><td></td></tr><tr><td>Working Hours/Day</td><td>3.79</td><td>1.41</td><td>10.18</td><td>0.0... |
75ff3692c584e4ab9323233d47e8124f2f2c00e7039658a7570d9d4dea94ad88.png | simple | <table><tr><td>Simulation Parameters</td><td>Value</td></tr><tr><td>map dimension</td><td>2 km × 1.5 km</td></tr><tr><td>Simulation time</td><td>1000 sec</td></tr><tr><td>Vehicle speed</td><td>0–15 m/s</td></tr><tr><td>Velocity threshold</td><td>7 m/s</td></tr><tr><td>MAC/PHY</td><td>IEEE 802.11p</td></tr><t... | <table><tr><td>Simulation Parameters</td></tr><tr><td>map dimension</td></tr><tr><td>Simulation time</td></tr><tr><td>Vehicle speed</td></tr><tr><td>Velocity threshold</td></tr><tr><td>MAC/PHY</td></tr><tr><td>Vehicle density</td></tr><tr><td>Route generator</td></tr></table> | <table><tr><td>Value</td></tr><tr><td>2 km × 1.5 km</td></tr><tr><td>1000 sec</td></tr><tr><td>0–15 m/s</td></tr><tr><td>7 m/s</td></tr><tr><td>IEEE 802.11p</td></tr><tr><td>100–500</td></tr><tr><td>SUMO</td></tr></table> |
fb9e41fa0698366be1a7d74cbc5b11a6dca775a07ef6d850a0b61d07309463da.png | complex | <table><tr><td rowspan="2"></td><td>HFNO group</td><td>Venturi mask group</td><td rowspan="2"><i>P</i> value</td></tr><tr><td>(n = 52)</td><td>(n = 48)</td></tr><tr><td colspan="4">Primary endpoint</td></tr><tr><td> Number (%) of patients requiring mechanical ventilation</td><td>8 (15 %)</td><td>4 (8 %)</td><td rowspan... | <table><tr><td rowspan="2"></td><td>HFNO group</td><td>Venturi mask group</td><td rowspan="2">P value</td></tr><tr><td>(n = 52)</td><td>(n = 48)</td></tr><tr><td colspan="4">Primary endpoint</td></tr><tr><td>Number (%) </td><td>8 (1</td><td>4 (8</td><td>0.3</td></tr></table> | <table><tr><td>of patients requiring mechanical ventilation</td><td>5 %)</td><td> %)</td><td rowspan="3">6</td></tr><tr><td>Noninvasive mechanical ventilation</td><td>6a</td><td>3a</td></tr><tr><td>Invasive mechanical ventilation</td><td>4</td><td>2</td></tr><tr><td colspan="4">Secondary endpoints, median [25th–75th pe... |
4fe8a6a9235fc5eb54a553cf8403ff6674dd0a0e0dc2df2859bc1d6c6599fa1e.png | simple | <table><tr><td>Gene-set ID</td><td>Gene-set Description</td><td>Gene N#</td></tr><tr><td>hi015</td><td>Predicted haploinsufficiency (most inclusive)</td><td>8862</td></tr><tr><td>hi035</td><td>Predicted haploinsufficiency</td><td>4136</td></tr><tr><td>hi055</td><td>Predicted haploinsufficiency (most stringent)</td><td>... | <table><tr><td>Gene-set ID</td><td>Gene-set Description</td><td>Gene N#</td></tr><tr><td>hi015</td><td>Predicted haploinsufficiency (most inclusive)</td><td>8862</td></tr><tr><td>hi035</td><td>Predicted haploinsufficiency</td><td>4136</td></tr><tr><td>hi055</td><td>Predicted haploinsufficiency (most stringent)</td><td>... | <table><tr><td>PhHs_NervSys_All</td><td>Human nervous system phenotype (HPO)</td><td>784</td></tr><tr><td>PhHs_MindFun_ADX</td><td>Higher mental function phenotype (HPO), autosomal dominant or X-linked</td><td>395</td></tr><tr><td>PhHs_MindFun_All</td><td>Higher mental function phenotype (HPO)</td><td>687</td></tr><tr>... |
0de74ca5e38138650b78a7035d5b62308ac0f1d381aca860e377769994e00d3e.png | complex | <table><tr><td> </td><td colspan="2">P1</td><td colspan="2">N1</td><td colspan="2">P2</td></tr><tr><td> </td><td>Latency (ms)</td><td>Amplitude (microvolts)</td><td>Latency (ms)</td><td>Amplitude (microvolts)</td><td>Latency (ms)</td><td>Amplitude (microvolts)</td></tr><tr><td>Older nonmusicians</td><td>65 (8)</td><td>... | <table><tr><td></td><td colspan="2">P1</td><td colspan="2">N1</td><td colspan="2">P2</td></tr><tr><td></td><td>Latency (ms)</td><td>Amplitude (microvolts)</td><td>Latency (ms)</td><td>Amplitude (microvolts)</td><td>Latency (ms)</td><td>Amplitude (microvolts)</td></tr><tr><td>Older nonmusicians</td><td>65 (8)</td><td>2.... | <table><tr><td></td><td colspan="2">P1</td><td colspan="2">N1</td><td colspan="2">P2</td></tr><tr><td></td><td>Latency (ms)</td><td>Amplitude (microvolts)</td><td>Latency (ms)</td><td>Amplitude (microvolts)</td><td>Latency (ms)</td><td>Amplitude (microvolts)</td></tr><tr><td>Older musicians</td><td>61 (8)</td><td>2.24 ... |
fd1385eb0dd1f7ee5485c2ff5217eb847aa68b1105df388fe9b2ee1cf410dab1.png | complex | <table><tr><td rowspan="2">Variable</td><td colspan="2">Time Period 1: April 6-May 5</td><td colspan="2">Time period 2: Aug 4- Sept 2</td><td colspan="2">Time period 3: Oct 3-Nov 1</td><td>Total</td></tr><tr><td>Cluster 1</td><td>Outside cluster 1</td><td>Cluster 2</td><td>Outside cluster 2</td><td>Cluster 3</td><td>Ou... | <table><tr><td>Variable</td><td colspan="2">Time Period 1: April 6-May 5</td><td colspan="2">Time period 2: Aug 4- Sept 2</td><td colspan="2">Time period 3: Oct 3-Nov 1</td><td>Total</td></tr></table> | <table><tr><td>Variable</td><td>Cluster 1</td><td>Outside cluster 1</td><td>Cluster 2</td><td>Outside cluster 2</td><td>Cluster 3</td><td>Outside cluster 3</td><td>All cases 2010</td></tr><tr><td>Number of Cases</td><td>62</td><td>36</td><td>58</td><td>54</td><td>17</td><td>49</td><td>1,134</td></tr><tr><td>% Male</td>... |
0e31c0b56e3b12898521d00f8852fd4517bbc305e954114f5ce82d5a4b150bd0.png | complex | <table><tr><td rowspan="2">Performance objectives</td><td colspan="2">Determinants</td></tr><tr><td>Information/knowledge</td><td>Self-efficacy/skills</td></tr><tr><td>To own LLINs</td><td>Explain the benefits of LLINs ownership</td><td>Demonstrate how a net should be used</td></tr><tr><td>To fight bedbugs</td><td>Expl... | <table><tr><td rowspan="2">Performance objectives</td><td colspan="2">Determinants</td></tr><tr><td>Information/knowledge</td><td>Self-efficacy/skills</td></tr><tr><td>To own LLINs</td><td>Explain the benefits of LLINs ownership</td><td>Demonstrate how a net should be used</td></tr><tr><td>To fight bedbugs</td><td>Expl... | <table><tr><td rowspan="2">Performance objectives</td><td colspan="2">Determinants</td></tr><tr><td>Information/knowledge</td><td>Self-efficacy/skills</td></tr><tr><td>To use LLINs every night</td><td>Explain the importance of using LLINs every night</td><td>Use of LLINs in spite of warm weather or weather changes</td>... |
869965179101c4df6535aaa53208747fa1c9bee1675dbfe8b02ba7a9094996a9.png | complex | <table><tr><td>NA added (μmol L<sup>-1</sup>)</td><td>NA found (μmol·L<sup>-1</sup>)</td><td>RSD (%)</td><td>Recovery (%)</td><td>Mean (%)</td></tr><tr><td>10.00</td><td>9.832</td><td>3.4</td><td>98.3</td><td rowspan="5">101.8</td></tr><tr><td>40.00</td><td>41.03</td><td>2.1</td><td>102.6</td></tr><tr><t... | <table><tr><td>NA added (μmol L-1)</td></tr><tr><td>10.00</td></tr><tr><td>40.00</td></tr><tr><td>50.00</td></tr><tr><td>70.00</td></tr><tr><td>90.00</td></tr></table> | <table><tr><td>NA found (μmol·L-1)</td><td>RSD (%)</td><td>Recovery (%)</td><td>Mean (%)</td></tr><tr><td>9.832</td><td>3.4</td><td>98.3</td><td rowspan="5">101.8</td></tr><tr><td>41.03</td><td>2.1</td><td>102.6</td></tr><tr><td>52.23</td><td>2.7</td><td>104.5</td></tr><tr><td>69.42</td><td>1.9</td><td>99.2</td></tr><t... |
5bf350a3d13455376126b3e5a8ec562a6f82d28b32364d0a98e4874133dfea20.png | simple | <table><tr><td>Company</td><td>Founded</td><td>Guidance and usage</td></tr><tr><td>EDAP TMS</td><td>1979</td><td>US</td></tr><tr><td>SonaCare Medical (previously US-HIFU, International HIFU and Focus Surgery)</td><td>1997</td><td>US</td></tr><tr><td>Chongqing HAIFU</td><td>1999</td><td>Both</td></tr><tr><td>China Medic... | <table><tr><td>Company</td><td>Founded</td><td>Guidance and usage</td></tr><tr><td>EDAP TMS</td><td>1979</td><td>US</td></tr><tr><td>SonaCare Medical (previously US-HIFU, International HIFU and Focus Surgery)</td><td>1997</td><td>US</td></tr><tr><td>Chongqing HAIFU</td><td>1999</td><td>Both</td></tr><tr><td>China Medic... | <table><tr><td>Company</td><td>Founded</td><td>Guidance and usage</td></tr><tr><td>Kona Medical</td><td>2009</td><td>US</td></tr><tr><td>Histosonic</td><td>2009</td><td>US</td></tr><tr><td>FUS instruments</td><td>2009</td><td>MR—animals</td></tr><tr><td>Acublate</td><td>2010</td><td>Both</td></tr></table> |
fc7e988d8438931ce7331cc1ed4a975eecaf52fc2efb1b537277fd356016ff79.png | complex | <table><tr><td>Complex</td><td>H-bond/vdW contact AH..B/A..B</td><td><i>E</i><sup>(2)</sup>, kcal/mol</td><td><i>C</i>str, Å/mDyn</td></tr><tr><td>1</td><td>C1H...O2</td><td>0.36</td><td>39.549</td></tr><tr><td>2</td><td>C1H...N3</td><td>1.00</td><td>22.928</td></tr><tr><td rowspan="2">3</td><td>C1H...O2</td><td>... | <table><tr><td>Complex</td><td>H-bond/vdW contact AH..B/A..B</td><td>E(2), kcal/mol</td><td>Cstr, Å/mDyn</td></tr><tr><td>1</td><td>C1H...O2</td><td>0.36</td><td>39.549</td></tr><tr><td>2</td><td>C1H...N3</td><td>1.00</td><td>22.928</td></tr><tr><td rowspan="2">3</td><td>C1H...O2</td><td>0.76</td><td>37.566</td></tr><... | <table><tr><td>10</td><td>6H...O2</td><td>.98</td><td>9</td></tr></table> |
f7e40af5645bff915387a079978776c0cd885380168cd352a7d1cbe1b97b7581.png | complex | <table><tr><td rowspan="2">Nomenclature</td><td rowspan="2">rs</td><td rowspan="2">Nucleotide changes</td><td rowspan="2">Effect</td><td rowspan="2">n</td><td colspan="3">Genotype frequencies, %</td><td colspan="2">Allele frequencies, %</td></tr><tr><td>wt</td><td>ht</td><td>vt</td><td>p</td><td>q</td></tr><tr><td> <i>... | <table><tr><td>Nome</td><td>rs</td><td>Nucleotide chang</td><td>Effec</td><td>n</td><td colspan="3">Genotype frequenc</td><td colspan="2">Allele</td></tr></table> | <table><tr><td rowspan="2">nclature</td><td rowspan="2"></td><td rowspan="2">es</td><td rowspan="2">t</td><td rowspan="2"></td><td colspan="3">ies, %</td><td colspan="2"> frequencies, %</td></tr><tr><td>wt</td><td>ht</td><td>vt</td><td>p</td><td>q</td></tr><tr><td>CYP2C8*2</td><td>rs11572103</td><td>T805A</td><td>I269F... |
f408a15449d143d9e355c8df3e1511bf3c2b1a37c5f0e8656fc06d43a2fc2e36.png | complex | <table><tr><td rowspan="2"> </td><td>Patients with anti-C1q autoantibodies</td><td>Patients without anti-C1q autoantibodies</td><td rowspan="2">r value(<i>P </i>value)</td><td>Patients with levels of C1q above 40.97 μg/ml</td><td>Patients with levels of C1q under 40.97 μg/ml</td><td rowspan="2">r value(<i>P <... | <table><tr><td rowspan="2"></td><td>Patients with anti-C1q autoantibodies</td><td>Patients without anti-C1q autoantibodies</td><td rowspan="2">r value(P value)</td><td>Patients with levels of C1q above 40.97 μg/ml</td><td>Patients with levels of C1q under 40.97 μg/ml</td><td rowspan="2">r value(P value)</td></tr><tr><t... | <table><tr><td>Interstitial inflammation</td><td>1(0,3)</td><td>1(0,3)</td><td>NS</td><td>1(0,3)</td><td>1(0,3)</td><td>NS</td></tr><tr><td>Leukocyte infiltration</td><td>1(0,3)</td><td>1(0,3)</td><td>0.159(0.019)</td><td>1(0,3)</td><td>1(0,3)</td><td>−0.246(<0.001)</td></tr><tr><td>Chronicity Indices score</td><td>2(0... |
04992532a98aa9e7feb033aab87b06c83ab830231403ebbf714cf20dc5a3b3e0.png | complex | <table><tr><td rowspan="2">Treatment type</td><td colspan="3">IC<sub>50</sub> values (μM)</td></tr><tr><td>on HepG2 cells</td><td>on A549 cells</td><td>on B16 cells</td></tr><tr><td>Duopafei<sup>®</sup></td><td>0.96 ± 0.05</td><td>0.74 ± 0.02</td><td>0.72 ± 0.10</td></tr><tr><td>DTX-micelles</t... | <table><tr><td rowspan="2">Tre</td><td colspan="3">IC50 values (μM)</td></tr><tr><td>on HepG2</td><td>on A549</td><td>on B1</td></tr></table> | <table><tr><td>atment type</td><td> cells</td><td> cells</td><td>6 cells</td></tr><tr><td>Duopafei®</td><td>0.96 ± 0.05</td><td>0.74 ± 0.02</td><td>0.72 ± 0.10</td></tr><tr><td>DTX-micelles</td><td>0.34 ± 0.02**</td><td>0.44 ± 0.05*</td><td>0.49 ± 0.08**</td></tr><tr><td>Blank micelles</td><td>12.84 ± 0.12</td><td>29.6... |
8a697dff010fe315dc419e0d20b4227428f45bb5ff84e6aed5a5ef1ff6719904.png | complex | <table><tr><td></td><td colspan="3">Tusablea</td></tr><tr><td>Algorithm</td><td>Eight</td><td>Eleven</td><td>Twelve</td></tr><tr><td>Random Tweak</td><td>1.99</td><td>8.47</td><td>10.17</td></tr><tr><td>CCDb</td><td>159.46</td><td>511.10</td><td>527.77</td></tr><tr><td>Wriggling</td><td>5.67</td><td>28.50</td><td>22.50... | <table><tr><td></td><td colspan="3">Tusablea</td></tr><tr><td>Algorithm</td><td>Eight</td><td>Eleven</td><td>Twelve</td></tr><tr><td>Random Tweak</td><td>1.99</td><td>8.47</td><td>10.17</td></tr></table> | <table><tr><td>CCDb</td><td>159.46</td><td>511.10</td><td>527.77</td></tr><tr><td>Wriggling</td><td>5.67</td><td>28.50</td><td>22.50</td></tr><tr><td>PLOP-build</td><td>3.39</td><td>35.00</td><td>71.67</td></tr><tr><td>Direct Tweak</td><td>34.00</td><td>73.44</td><td>75.65</td></tr><tr><td>LOOPYbb</td><td>22.86</td><td... |
a8b094e408ada60383d16bf6364d2a9496f64356687501f04bfe3de70c78bcaa.png | complex | <table><tr><td rowspan="2">Characteristic</td><td>Round 1</td><td>Round 2</td></tr><tr><td>n-size</td><td>n-size</td></tr><tr><td>Response rate</td><td>46</td><td>22</td></tr><tr><td colspan="3">Subjects</td></tr><tr><td>Male / Female</td><td>30/8</td><td>15/6</td></tr><tr><td colspan="3">Location</td></tr><tr><td>Euro... | <table><tr><td rowspan="2">Characteristic</td><td>Round 1</td><td>Round 2</td></tr><tr><td>n-size</td><td>n-size</td></tr><tr><td>Response rate</td><td>46</td><td>22</td></tr><tr><td colspan="3">Subjects</td></tr><tr><td>Male / Female</td><td>30/8</td><td>15/6</td></tr><tr><td colspan="3">Location</td></tr><tr><td>Euro... | <table><tr><td rowspan="2">Characteristic</td><td>Round 1</td><td>Round 2</td></tr><tr><td>n-size</td><td>n-size</td></tr><tr><td>Transport</td><td>2</td><td>1</td></tr><tr><td>Policy</td><td>1</td><td>1</td></tr><tr><td>Nutrition</td><td>1</td><td>1</td></tr><tr><td>Environmental health</td><td>1</td><td>-</td></tr><t... |
568049ed0d65229a57481ee075240e730ab71dabda8a9f05ac4026e46883c143.png | complex | <table><tr><td>Age – group</td><td>Number</td><td>(%)</td></tr><tr><td>20 - 29</td><td>7</td><td>12.5%</td></tr><tr><td>30 - 39</td><td>10</td><td>17.9%</td></tr><tr><td>40 - 49</td><td>12</td><td>21.4%</td></tr><tr><td>50 - 59</td><td>17</td><td>30.4%</td></tr><tr><td>≥ 60</td><td>10</td><td>17.9%</td></tr... | <table><tr><td>Age – group</td><td>Number</td><td>(%)</td></tr><tr><td>20 - 29</td><td>7</td><td>12.5%</td></tr><tr><td>30 - 39</td><td>10</td><td>17.9%</td></tr><tr><td>40 - 49</td><td>12</td><td>21.4%</td></tr></table> | <table><tr><td>Age – group</td><td>Number</td><td>(%)</td></tr><tr><td>50 - 59</td><td>17</td><td>30.4%</td></tr><tr><td>≥ 60</td><td>10</td><td>17.9%</td></tr><tr><td>Total</td><td>56</td><td>100%</td></tr><tr><td>Mean ± SD = 44.96 ± 13.80</td><td colspan="2">Range = (21,80)</td></tr><tr><td>SEX</td><td>Number</td><td... |
b4576eedfb69a95f7a1835e59a796205593f4e6eb6df9ed3adc7aa7a07667060.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">Whole cohort</td><td colspan="2">HSES</td><td colspan="2">LSES</td><td rowspan="2"><i>p</i> value*</td></tr><tr><td><i>N</i></td><td>Mean (SD)</td><td><i>N</i></td><td>Mean (SD)</td><td><i>N</i></td><td>Mean (SD)</td></tr><tr><td>Age (years)</td><td>1343</td><td>8.0 (2.4)... | <table><tr><td rowspan="2"></td><td colspan="2">Whole cohort</td><td colspan="2">HSES</td><td colspan="2">LSES</td><td rowspan="2">p value*</td></tr><tr><td>N</td><td>Mean (SD)</td><td>N</td><td>Mean (SD)</td><td>N</td><td>Mean (SD)</td></tr><tr><td>Age (years)</td><td>1343</td><td>8.0 (2.4)</td><td>673</td><td>8.0 (2.... | <table><tr><td rowspan="2"></td><td colspan="2">Whole cohort</td><td colspan="2">HSES</td><td colspan="2">LSES</td><td rowspan="2">p value*</td></tr><tr><td>N</td><td>Mean (SD)</td><td>N</td><td>Mean (SD)</td><td>N</td><td>Mean (SD)</td></tr><tr><td>Child BMI (kg/m2)</td><td>1343</td><td>15.9 (2.2)</td><td>673</td><td>... |
70f845bddfff049f4ceeb4ab19ad96b7bce864cc98792cbea93f913b6dfb813a.png | simple | <table><tr><td></td><td>Crohn's disease</td><td>Healthy controls</td></tr><tr><td>Number (Male/Female)</td><td>16 (7/9)</td><td>16 (9/7)</td></tr><tr><td>Median [range] age (years)</td><td>42 [22-66]</td><td>33 [22-62]</td></tr><tr><td>Disease location</td><td>L1: 2</td><td>-</td></tr><tr><td></td><td>L2: 6</td><td>-</... | <table><tr><td></td><td>Crohn's disease</td><td>Healthy controls</td></tr><tr><td>Number (Male/Female)</td><td>16 (7/9)</td><td>16 (9/7)</td></tr><tr><td>Median [range] age (years)</td><td>42 [22-66]</td><td>33 [22-62]</td></tr><tr><td>Disease location</td><td>L1: 2</td><td>-</td></tr><tr><td></td><td>L2: 6</td><td>-</... | <table><tr><td></td><td></td><td></td></tr><tr><td>Previous bowel resection</td><td>6</td><td></td></tr></table> |
dfd3cf20c0e51b642c89a67ce390e4516b06aeb0ef9486b4e1981362ad2c46ac.png | complex | <table><tr><td> </td><td colspan="6"><i>S. aureus </i>isolate</td></tr><tr><td>Antibiotic</td><td>#1</td><td>#2*</td><td>#6</td><td>#18</td><td>#19</td><td>#20</td></tr><tr><td>Cefazolin</td><td>0.11</td><td>0.55</td><td>0.08</td><td>0.13</td><td>0.12</td><td>0.36</td></tr><tr><td>Cefoxitin</td><td>0.11</td><td>0.64</t... | <table><tr><td></td><td colspan="6">S. aureus isolate</td></tr><tr><td>Antibio</td><td>#</td><td>#</td><td>#6</td><td></td><td>#1</td><td>#20</td></tr></table> | <table><tr><td>tic</td><td>1</td><td>2*</td><td></td><td>#18</td><td>9</td><td></td></tr><tr><td>Cefazolin</td><td>0.11</td><td>0.55</td><td>0.08</td><td>0.13</td><td>0.12</td><td>0.36</td></tr><tr><td>Cefoxitin</td><td>0.11</td><td>0.64</td><td>0.09</td><td>0.12</td><td>0.12</td><td>0.30</td></tr><tr><td>Cefepime</td>... |
ca8971ef303735cf5733f7f59eec9bac0c8c18af09f85a1d698a308de1463faf.png | simple | <table><tr><td><i>Mz</i><sub>max</sub></td><td><i>SS</i></td><td><i>DF</i></td><td><i>RMC</i></td><td><i>F</i>-Ratio</td><td><i>P</i>-Value</td><td>Contribution (%)</td></tr><tr><td><i>N</i></td><td>0.5677</td><td>2</td><td>0.2838</td><td>7.75</td><td>0.0010</td><td>4.86</td></tr><tr><td><i>F</i></td><td>0.4028</td><td... | <table><tr><td>Mzmax</td><td>SS</td><td>DF</td><td>RMC</td><td>F-Ratio</td><td>P-Value</td><td>Contribution (%)</td></tr><tr><td>N</td><td>0.5677</td><td>2</td><td>0.2838</td><td>7.75</td><td>0.0010</td><td>4.86</td></tr><tr><td>F</td><td>0.4028</td><td>2</td><td>0.2014</td><td>5.50</td><td>0.0063</td><td>3.45</td></tr... | <table><tr><td>N–F</td><td>1.3567</td><td>4</td><td>0.3392</td><td>9.26</td><td><0.0001</td><td>11.63</td></tr><tr><td>N–B</td><td>1.6521</td><td>4</td><td>0.4130</td><td>11.28</td><td><0.0001</td><td>14.16</td></tr><tr><td>F–B</td><td>0.3234</td><td>4</td><td>0.0808</td><td>2.21</td><td>0.0784</td><td>2.77</td></tr><t... |
6f3d3b8721b0cb3a6ae7af66a95110b711c099f24935028207cda9b91c85333a.png | simple | <table><tr><td>Background characteristics</td><td>Percent</td><td>Selected independent variables</td><td>Percent</td></tr><tr><td>Maternal age (years)</td><td>27.3 ± 5.5*</td><td>Mode of delivery</td><td> </td></tr><tr><td>15–24</td><td>38.0</td><td>Vaginal delivery</td><td>37.4</td></tr><tr><td>25–29<... | <table><tr><td>Background characteristics</td><td>Percent</td><td>Selected independent variables</td><td>Percent</td></tr><tr><td>Maternal age (years)</td><td>27.3 ± 5.5*</td><td>Mode of delivery</td><td></td></tr><tr><td>15–24</td><td>38.0</td><td>Vaginal delivery</td><td>37.4</td></tr><tr><td>25–29</td><td>34.3</td><... | <table><tr><td>hild</td><td>0</td><td>uring pregnancy</td><td>4.1</td></tr><tr><td>Rural area of residence</td><td>83.3</td><td>During first 3 days after delivery</td><td>31.6</td></tr><tr><td>SES in quartiles</td><td>25.0</td><td>Exposure to infant feeding messages on TV in past 30 days</td><td></td></tr><tr><td></td>... |
aa50aea81fa2d9c5b145fb83f4f364827221e18c1a46d868309a858c10f67f65.png | complex | <table><tr><td></td><td></td><td></td><td></td><td colspan="3">100,000<sup>a</sup></td><td></td></tr><tr><td>Expected molecules target</td><td>1,000,000</td><td>200,000</td><td>150,000</td><td>A</td><td>B</td><td>C</td><td>10,000</td></tr><tr><td>Observed molecules target<sup>b</sup></td><td>1,173,333</td><td>290,000</... | <table><tr><td></td><td></td><td></td><td></td><td colspan="3">100,000a</td><td></td></tr><tr><td>Expected molecules target</td><td>1,000,000</td><td>200,000</td><td>150,000</td><td>A</td><td>B</td><td>C</td><td>10,000</td></tr></table> | <table><tr><td>Observed molecules targetb</td><td>1,173,333</td><td>290,000</td><td>255,000</td><td>115,000</td><td>110,667</td><td>97,333</td><td>11,200</td></tr><tr><td>SD</td><td>161,658</td><td>35,000</td><td>91,788</td><td>5,000</td><td>9,292</td><td>3,055</td><td>2,081</td></tr><tr><td>CV</td><td>13.78%</td><td>1... |
7d2a1a96b3145c5122707695aac59f4f877c45f1e5d25c27e6f4d9f3a6565a75.png | complex | <table><tr><td colspan="2">Characteristics</td><td>Frequency</td><td>%</td></tr><tr><td rowspan="2">Gender</td><td>Male</td><td>230</td><td>57.50</td></tr><tr><td>Female</td><td>170</td><td>42.50</td></tr><tr><td rowspan="3">Level of selfitis</td><td>Borderline</td><td>136</td><td>34.00</td></tr><tr><td>Acute</td><td>1... | <table><tr><td colspan="2">Characteristics</td><td>Frequency</td></tr><tr><td rowspan="2">Gender</td><td>Male</td><td>230</td></tr><tr><td>Female</td><td>170</td></tr><tr><td rowspan="3">Level of selfitis</td><td>Borderline</td><td>136</td></tr><tr><td>Acute</td><td>162</td></tr><tr><td>Chronic</td><td>102</td></tr><tr... | <table><tr><td>%</td></tr><tr><td>57.50</td></tr><tr><td>42.50</td></tr><tr><td>34.00</td></tr><tr><td>40.50</td></tr><tr><td>25.50</td></tr><tr><td>56.00</td></tr><tr><td>34.00</td></tr><tr><td>06.75</td></tr><tr><td>03.25</td></tr><tr><td>55.75</td></tr><tr><td>35.25</td></tr><tr><td>09.00</td></tr><tr><td>34.00</td>... |
1f3f2c80feae4fcdf0d9d233a83c326364306a33d4c458a9ca8e8eaad485093d.png | complex | <table><tr><td></td><td>Baseline</td><td colspan="4">Outcomes</td></tr><tr><td>Measure</td><td></td><td>1 Month</td><td>3 Month</td><td>6 Month</td><td>12 Month</td></tr><tr><td>Demographic factors</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Age, sex, race/ethnicity, educational attainment, employment... | <table><tr><td></td><td>Baseline</td><td colspan="4">Outcomes</td></tr><tr><td>Measure</td><td></td><td>1 Month</td><td>3 Month</td><td>6 Month</td><td>12 Month</td></tr><tr><td>Demographic factors</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Age, sex, race/ethnicity, educational attainment, employment... | <table><tr><td>Quit attempt (>24 hours)</td><td>X</td><td>X</td><td></td><td></td><td></td></tr><tr><td>Hospital admission or emergency room visit</td><td></td><td>X</td><td>X</td><td>X</td><td></td></tr><tr><td>Quality of life (EQ-5D)</td><td>X</td><td></td><td></td><td>X</td><td></td></tr><tr><td>Anxiety and depressi... |
47b7b003ae6617547a5fdcfafc8673d3025cbc8e33cea5b6bd61ef7862f58ee2.png | simple | <table><tr><td>Indicators Groups (IG)</td><td>Number of species per IG</td><td>Number of grid cells required to represent all species from each IG</td><td>Percentage of species represented by IG (%)</td><td>Land cost-effective by IG ($)</td></tr><tr><td>Brachycephalidae</td><td>35</td><td>9</td><td>63</td><td>30,929,85... | <table><tr><td>Indicators Groups (IG)</td><td>Number of species per IG</td><td>Number of grid cells required to represent all species from each IG</td><td>Percentage of species represented by IG (%)</td><td>Land cost-effective by IG ($)</td></tr><tr><td>Brachycephalidae</td><td>35</td><td>9</td><td>63</td><td>30,929,85... | <table><tr><td>eptodactylidae</td><td></td><td></td><td>65</td><td>7,803,150</td></tr><tr><td>Microhylidae</td><td>21</td><td>8</td><td>59</td><td>27,493,200</td></tr></table> |
28921364d10545e9c13bcb54b58be6e321012129302a8d36c94ace71b486e0e9.png | complex | <table><tr><td rowspan="2">Locus</td><td rowspan="2">Fragment</td><td colspan="2">PCR product length (bp)</td><td colspan="2">Number of tandem repeats</td></tr><tr><td>Fragment analysis</td><td>Sequencing</td><td>Fragment analysis<sup>1</sup></td><td>Sequencing</td></tr><tr><td>Ms27</td><td>1</td><td>285</td><td>282</t... | <table><tr><td rowspan="2">Locus</td><td rowspan="2">Fragment</td><td colspan="2">PCR product length (bp)</td><td colspan="2">Number of tandem repeats</td></tr><tr><td>Fragment analysis</td><td>Sequencing</td><td>Fragment analysis1</td><td>Sequencing</td></tr><tr><td>Ms27</td><td>1</td><td>285</td><td>282</td><td>2.4</... | <table><tr><td rowspan="2">Locus</td><td rowspan="2">Fragment</td><td colspan="2">PCR product length (bp)</td><td colspan="2">Number of tandem repeats</td></tr><tr><td>Fragment analysis</td><td>Sequencing</td><td>Fragment analysis1</td><td>Sequencing</td></tr><tr><td></td><td>4</td><td>136</td><td>142</td><td>6.1</td><... |
af373c4874f551b02588a5ba0213168f852519bcb82f32271ce8a120a20956e5.png | complex | <table><tr><td rowspan="2">Loci</td><td colspan="4">Male</td><td colspan="4">Female</td></tr><tr><td>NC (%)</td><td>AITD (%)</td><td><i>P</i> value</td><td>OR/95% CI</td><td>NC (%)</td><td>AITD (%)</td><td><i>P</i> value</td><td>OR/95% CI</td></tr><tr><td>rs2046068</td><td> </td><td> </td><td> </td><td> </td><td> </td>... | <table><tr><td rowspan="2">Loci</td><td colspan="4">Male</td><td colspan="4">Female</td></tr><tr><td>NC (%)</td><td>AITD (%)</td><td>P value</td><td>OR/95% CI</td><td>NC (%)</td><td>AITD (%)</td><td>P value</td><td>OR/95% CI</td></tr><tr><td>rs2046068</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><... | <table><tr><td rowspan="2">Loci</td><td colspan="4">Male</td><td colspan="4">Female</td></tr><tr><td>NC (%)</td><td>AITD (%)</td><td>P value</td><td>OR/95% CI</td><td>NC (%)</td><td>AITD (%)</td><td>P value</td><td>OR/95% CI</td></tr><tr><td>GG</td><td>31 (10.92)</td><td>18 (7.73)</td><td></td><td></td><td>54 (9.52)</t... |
e50271e2fcc20a59bb5e8a28492141aa153f92abc5b7de5ab49ef323daad2b8b.png | simple | <table><tr><td>Biochemical category</td><td>Disease name</td><td>OMIM#</td><td>Gene(s)</td><td>Treatment</td><td>Effect</td><td>Level of evidence</td></tr><tr><td>Amino acids</td><td>PSAT deficiency</td><td>610992</td><td>PSAT1 (AR)</td><td>L-serine & +/−glycine supplements</td><td>Primary/targeting underlyin... | <table><tr><td>Biochemical category</td><td>Disease name</td><td>OMIM#</td><td>Gene(s)</td><td>Treatment</td><td>Effect</td><td>Level of evidence</td></tr><tr><td>Amino acids</td><td>PSAT deficiency</td><td>610992</td><td>PSAT1 (AR)</td><td>L-serine & +/−glycine supplements</td><td>Primary/targeting underlying pathophy... | <table><tr><td></td><td>PSPH deficiency (Serine deficiency)</td><td>614023</td><td>PSPH (AR)</td><td>L-serine & +/−glycine supplements</td><td>Primary/targeting underlying pathophysiology</td><td>4</td></tr><tr><td>Creatine</td><td>Arginine:glycine amidinotransferase (AGAT) deficiency</td><td>612718</td><td>GATM (AR)</... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.